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The role of the P2Y2 nucleotide receptor in inflammation: the 
mechanisms of P2Y2 receptor-mediated activation of G proteins 
        Zhongji Liao 
Dr. Gary A. Weisman and Dr. Laurie Erb, Dissertation Supervisors 
ABSTRACT 
Adenine and uridine nucleotides (ATP, ADP, UTP and UDP) have been 
well-recognized for their role in modulating vascular inflammation and thrombosis. 
These nucleotides are released in the vascular system by red blood cells exposed to low 
blood oxygen as well as by aggregating platelets, migrating leukocytes and damaged 
vascular cells.  Increasing evidence indicates that the extracellular ATP/UTP receptor, 
i.e., the P2Y2 receptor (P2Y2R), mediates mitogenic and pro-inflammatory responses in 
the vasculature, including increased smooth muscle cell proliferation and migration, and 
the endothelium-dependent infiltration of monocytes and their transmigration into sites of 
infection, injury, or stress, responses associated with the in vivo up-regulation of the P2Y2 
receptor in vascular cells (i.e., smooth muscle and endothelial cells). 
This dissertation concerns the mechanisms whereby the P2Y2R mediates chemotaxis 
as well as the modulation of endothelial intercellular junctions. Since G proteins, such as 
heterotrimeric G12 and Gi/o and the monomeric Rho family of GTPases, are responsible 
for regulating cellular actin dynamics and cytoskeletal changes that are central to 
chemotaxis and the stability of intercellular junctions, this dissertation focuses on the 
mechanisms underlying the P2Y2R-mediated activation of G proteins. 
The P2Y2R is a G protein-coupled receptor with an extracellular integrin binding 
domain (Arg-Gly-Asp or RGD) that enables this receptor to directly interact with αvβ3/β5 
xiv 
 
integrins, cell adhesion molecules known to regulate chemotaxis. Mutation of the RGD 
sequence to Arg-Gly-Glu (RGE) prevented association between the P2Y2R and αv 
integrins but did not prevent activation of Gq or Gq–mediated calcium mobilization by the 
P2Y2R agonist UTP. On the contrary, UTP-induced activation of G12 and G12-mediated 
events, including RhoA activation, cofilin and myosin light chain-2 phosphorylation, 
stress fiber formation and chemotaxis were all inhibited by mutation of the RGD domain 
to RGE in the human P2Y2R expressed in human 1312N1 astrocytoma cells that are 
devoid of endogenous P2 nucleotide receptors. Similarly, UTP-induced activation of Go 
and Go-mediated events, including activation of Rac and vav2, a guanine nucleotide 
exchange factor for Rac, as well as chemotaxis towards UTP, were inhibited by the RGD 
to RGE mutation in the P2Y2R. These responses were also inhibited by anti-αvβ5 integrin 
antibodies or αv integrin-specific antisense oligonucleotides, further confirming that αv 
integrin activity and expression are required for the P2Y2R to activate Go and G12, and 
subsequently, chemotaxis. Involvement of Go and G12 in these UTP-triggered events was 
confirmed using the Gi/o inhibitor, pertussis toxin or dominant negative Gα12. Thus, the 
interaction between the P2Y2R and αv integrin is required for the P2Y2R to activate 
heterotrimeric Go and G12 proteins that control chemotaxis.   
In migrating leukocytes, P2Y2Rs remain evenly distributed on the cell surface and 
are thought to provide directional sensing and amplification of chemotactic signals by 
sensing nucleotides released at the leading edge of the migrating cell.  In chapter IV of 
this study, we analyzed the distribution of P2Y2Rs in quiescent endothelial cells.  
Activation of P2Y2Rs with the agonist UTP caused a rapid and transient clustering of 
GFP-tagged P2Y2Rs at the intercellular junctions of human coronary artery endothelial 
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cells (HCAEC). Co-immunoprecipitation experiments indicate that UTP causes a rapid 
and transient association of the P2Y2R and the vascular endothelial growth factor 
receptor-2 (VEGFR-2) with VE-cadherin, a transmembrane component of endothelial 
adherens junctions. Given that UTP infusion around stressed vascular tissue has been 
found to increase monocyte infiltration through the endothelium in collared rabbit carotid 
arteries, this dissertation addresses the mechanisms underlying monocyte infiltration by 
investigating P2Y2R interaction with endothelial intercellular junction proteins. The Rho 
family of GTPases has been shown to regulate endothelial permeability and leukocyte 
transmigration by controlling cytoplasmic actin dynamics. However, it is not well 
understood how a G protein-coupled receptor (GPCR) and junctional proteins 
coordinately regulate Rho GTPase activity. This dissertation reports that siRNA-mediated 
down-regulation of VE-cadherin or p120 catenin, a protein known to associate with 
VE-cadherin in adherens junctions, inhibited Rac activation induced by UTP.  In 
addition, UTP promoted a prolonged interaction between p120 catenin and vav2, a 
response that correlates with the tyrosine phosphorylation of VE-cadherin and p120 
catenin. UTP-induced responses, including the association of the P2Y2R with 
VE-cadherin, the association of p120 catenin with vav2, tyrosine phosphorylation of 
VE-cadherin and p120 catenin, and the activation of Rac, were inhibited by the Src 
inhibitor PP2 and the VEGFR-2 inhibitor SU1498, indicating that Src and VEGFR-2 
activity are required for controlling P2Y2R-initiated signaling to adherens junctions, 
consistent with the presence of SH3-binding motifs in the C-terminal domain of the 
P2Y2R known to regulate Src-dependent VEGFR-2 transactivation by the P2Y2R.  
Taken together, these data suggest that the P2Y2R requires direct interactions with αv 
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integrin, growth factor receptors and VE-cadherin to activate G proteins involved in 
chemotaxis and modulate the activities of intercellular junction proteins.  Although in 
different types of cells, the expression or distribution of P2Y2R-associated proteins may 
vary, this dissertation provides novel findings indicating that to be fully functional, the 
P2Y2Rs must couple to a large complex containing multiple receptors and signaling 
proteins, each of which could be a potential target for the prevention and treatment of 
inflammatory diseases. 
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           CHAPTER  I 
  Introduction 
A.  Inflammation 
Inflammation, a response triggered by trauma, toxin exposure, infection, ischemia 
and autoimmune injury, was recognized centuries ago. Today, chronic inflammation is 
considered to be a major factor in the pathophysiology of many diseases including 
rheumatoid arthritis, asthma, arteriosclerosis, diabetes and neurodegenerative diseases 
(Winsauer and de Martin, 2007). 
Over the last decade, a view has emerged that an inflammatory reaction does not 
occur in response to foreign molecules but rather to self molecules released from 
damaged tissue (Heath and Carbone, 2003; Matzinger, 1994). The ideal characteristics of 
a molecule that causes inflammation is predicted to have the following features:  
1. It should be easily and quickly generated, such as by release from a large 
intracellular pool into the extracellular environment.  
2. It should be present extracellularly at very low concentrations under normal 
conditions to allow a high response upon release under pro-inflammatory conditions. 
3. It should be easily transported or mobile in the pericellular environment. 
4. It should be recognized by specific receptors on affected tissues. 
5. It should be easily destroyed or masked to ensure a quick dampening of an 
inflammatory response. 
Extracellular nucleotides fulfill all these features, thus making them good candidates 
as ‘triggering’ molecules in inflammation. There is increasing evidence supporting the 
importance of extracellular nucleotides and their receptors in the development of many 
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inflammatory diseases. 
 
B. Endothelial-dependent mechanisms of leukocyte recruitment in inflammation 
The endothelium is a monolayer of cells that covers the inner surface of the entire 
vascular system, providing a barrier that separates circulating blood from the tissue. The 
endothelium senses different chemical or physical stimuli and responds by producing a 
large variety of molecules that regulate blood fluidity. The endothelium regulates 
homeostasis by producing anti-coagulant and pro-coagulant factors, synthesizes and 
releases both vasodilating factors (such as nitric oxide (NO), endothelium-derived 
hyperpolarizing factor (EDHF) and prostacyclin (PGI2)) and vasoconstricting factors 
(such as endothelium-derived contracting factors (EDCFs)), thus modulating the 
relaxation and contraction of vascular smooth muscle. The endothelium also participates 
in leukocyte recruitment and activation, and smooth muscle cell migration and 
proliferation during the inflammatory process ( Shimokawa, 1999; Esper et al., 2006). 
Loss of the capacity to maintain homeostasis (also called ‘endothelial dysfunction’) 
occurs under conditions of vascular injury or stress, such as hyperlipidemia, hypertension, 
smoking, diabetes, ischemia, and chronic bacterial infections. Endothelial dysfunction is 
accompanied by changes in the levels of cytokines, cell adhesion molecules, and other 
pro-inflammatory mediators, making local conditions favorable for the development of 
vascular inflammation (Winsauer and de Martin, 2007).  
During an inflammatory event, leukocytes traffic from the blood into the underlying 
tissues to the sites of infection or injury. The process of leukocyte emigration involves 
several major steps: the recruitment of leukocytes from bone marrow into the circulation, 
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leukocyte rolling and attachment on the endothelium, leukocyte migration to the 
endothelial cell borders, transendothelial migration of leukocytes (diapedesis) in an 
ameboid-like fashion, and chemotaxis of leukocytes towards chemoattractants released 
by injured tissue (Ley, 1996).  
Leukocyte recruitment requires specific interactions between endothelial cells and 
leukocytes to guide the migration of leukocytes from the blood to the sites of injury or 
infection. Leukocyte transendothelial migration is initiated by leukocyte rolling on the 
luminal surface of the endothelium, a process mediated by the low-affinity adhesion 
receptors termed selectins that weakly bind to glycoprotein ligands (McEver, 2002). 
Selectin-binding further activates β2 integrins on leukocytes, as ‘inside-out’ signals, 
leading to firm leukocyte adhesion to the endothelium (Simon et al., 2000). In addition, 
the rolling leukocyte can be stimulated by chemokines or other chemotactic molecules, 
which activate firm adhesion on the endothelium. For example, monocyte 
chemoattractant protein (MCP)-1 and interleukin (IL)-8 trigger the adhesion of 
monocytes through activation of the chemokine receptor, CCR2 (Gerszten et al., 1999). 
Leukocyte-endothelial adhesion is mediated by leukocyte surface integrins (β1 and β2 
integrins) and their counter-receptors on endothelial cells, such as vascular endothelial 
cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1, -2 (ICAM-1, 
-2) (Imhof and Aurrand-Lions, 2004).  
VCAM-1 preferentially recognizes α4β1 integrin, and it also binds to α4β7 integrin. 
VCAM-1 is considered to be the key molecule that mediates monocyte recruitment in 
early lesions and in vasculature predisposed to lesions (Cybulsky et al., 2001). 
Furthermore, VCAM-1 clustering generates endothelial cell ‘outside-in’ signals, such as 
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NADPH oxidase activation and endothelial cell actin reorganization, events thought to be 
important for VCAM-1-dependent lymphocyte migration, but not adhesion (Lorenzon et 
al., 1998; Matheny et al., 2000).  
The final step in leukocyte extravasation is migration through the endothelial cell 
borders, a process called diapedesis. Although there is recent evidence suggesting that 
leukocytes can migrate through the body of an endothelial cell (transcellular pathway) 
(Carman and Springer, 2004), it is believed that transendothelial migration is largely due 
to leukocyte migration through interendothelial junctions (paracellular pathway). 
Diapedesis involves a rapid reorganization of the leukocyte cytoskeleton, creating 
pseudopod-like extensions into the endothelial intercellular junction that enable leukocyte 
passage through the junction by the use of mechanical force generated by the pseudopod 
(Luscinskas et al., 2002). Meanwhile, the endothelium communicates with leukocytes to 
facilitate diapedesis while maintaining the endothelial integrity (Huang et al., 1988). For 
example, neutrophil transmigration causes a rise in intracellular Ca2+ levels that is 
localized in endothelial cells close to the migrating neutrophil and neutrophil 
transmigration is inhibited by the treatment of cells with intracellular Ca2+ chelators 
(Huang et al., 1993; Su et al., 2000).  
Endothelial junctions are composed of three morphologically distinct structures: tight 
junctions, adherens junctions and gap junctions. Molecular mechanisms regulating 
leukocyte transendothelial migration involve molecules present in tight junctions (i.e., 
junctional adhesion molecules or JAMs, occludin and claudin) and adherens junctions 
(i.e., VE-cadherin and catenins). Gap junctions are important for intercellular 
communication but are not thought to play a role in leukocyte transendothelial migration 
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(Luscinskas et al., 2002). In addition, platelet-endothelial cell adhesion molecule 
(PECAM)-1, a protein of the immunoglobulin (Ig) gene family, is localized to endothelial 
cell lateral junctions and has been shown to play a role in leukocyte transendothelial 
migration (Muller et al., 1993).  PECAM-1 is expressed in both leukocytes and 
endothelial cells and is capable of both homophilic interaction and heterophilic 
interaction with αvβ3 (Piali et al., 1995). Studies show that extracellular domains 1 and 2 
of leukocyte PECAM-1 are crucial for leukocyte transendothelial migration, whereas 
extracellular domain 6 is specifically important for interstitial migration (after 
transendothelial migration) (Liao et al., 1995). 
JAM-1 is present on the surface of endothelial cells as well as leukocytes. In vivo, the 
up-regulation of JAM-1 expression is found in unstable atherosclerotic plaques and in 
atherosclerotic endothelium. In vitro, rather than up-regulation, JAM-1 redistributes from 
endothelial intercellular junctions to the apical surface upon co-stimulation with the 
cytokines tumor-necrosis factor-α (TNFα) and interferon-γ (IFNγ) (Weber et al., 2007). 
Adherens junctions attract significant interest among research groups who study 
inflammation since they play an important role in leukocyte transendothelial migration. 
The adherens junction component, VE-cadherin, is a single transmembrane protein 
expressed exclusively in endothelial cells, with an extracellular domain responsible for 
Ca2+-dependent homophilic interaction and a cytoplasmic tail that connects to the actin 
cytoskeleton via association with catenins. It has been found that treatment with 
antibodies to VE-cadherin leads to increased endothelial permeability in vitro as well as 
leukocyte transmigration in vivo (Gotsch et al., 1997; Hordijk et al., 1999). In fact, 
monocyte adhesion/transendothelial migration is associated with a transient decrease in 
5 
 
VE-cadherin localization at cell contact sites under flow conditions (Allport et al., 2000). 
Real time imaging of endothelial cells expressing GFP-tagged VE-cadherin during 
leukocyte transendothelial migration provides an insight into the kinetics of this dynamic 
process. During real time imaging experiments under flow conditions, monocytes crawl 
to intercellular junctions of endothelial cells and then migrate through gaps (4-6 µm) in 
VE-cadherin junctional distribution, and within 5 minutes the VE-cadherin redistributes 
and reseals the gaps. Interestingly, a certain percentage of leukocytes transmigrate 
through pre-existing gaps instead of de novo gaps formed as leukocytes adhere, 
consistent with previous studies (using postfixation staining techniques) indicating that 
leukocytes can migrate through pre-existing gaps at the border of three or more 
endothelial cells (Burns et al., 2000; Shaw et al., 2001). In addition, it has been found that 
rather than paracellular transendothelial migration, fMLP-induced neutrophil 
transendothelial migration occurs by a transcellular pathway (Feng et al., 1998). In both 
cases, transendothelial migration requires an interaction between leukocytes and 
endothelial cells, cytoskeletal rearrangements in both cell types and the transduction of 
intracellular signals that regulate this dynamic process. 
After diapedesis, the leukocytes are directed by immobilized chemokines or by 
chemoattractant gradients to migrate across the endothelium and into the inflamed tissue. 
This directional migration is called chemotaxis, which will be discussed later in this 
chapter. 
 
C. Role of extracellular nucleotides in inflammation 
1. Extracellular nucleotides 
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Extracellular nucleotides are recognized as endogenous signaling molecules that 
function as hormones or neurotransmitters in a variety of mammalian cell types. Over the 
past few years, extracellular nucleotides have been characterized as an important factor 
modulating vascular inflammation and thrombosis (Di Virgilio and Solini, 2002). ATP, 
ADP, UTP and UDP are the major nucleotides that exert physiological effects through the 
activation of cell surface P2 nucleotide receptors that are known to regulate cardiac 
function, muscle relaxation and contraction, platelet aggregation, neurotransmission, 
inflammation, bone metabolism and cell growth (Dubyak and el-Moatassim, 1993; 
Hoebertz et al., 2003). Whereas intracellular concentrations of ATP are maintained at 
3-10 mM (Bours et al., 2006), and reach 1 M in nerve vesicles (Burnstock, 2006a), the 
extracellular concentration of ATP is much lower. In human plasma, the physiological 
concentration of ATP is usually submicromolar ( Ryan et al., 1991; Bours et al., 2006). 
Extracellular ATP can be released from secretory neuronal cells (Burnstock et al., 1978; 
Lew and White, 1987), aggregating platelets (Born and Kratzer, 1984), mast cells 
(Cockcroft and Gomperts, 1980), endothelial and smooth muscle cells (Pearson and 
Gordon, 1979), neutrophils (Chen et al., 2006), and from many cell types in response to 
mechanical or chemical stress including distention, osmotic shock, hypoxia, agonist 
stimulation, fluid shear stress and acute inflammation. (Bodin and Burnstock, 2001; 
Burnstock, 2006b). Several mechanisms of ATP release have been proposed but remain 
unclear. Besides the accepted theory of vesicular release from nerves and platelets, there 
is evidence of ‘cytolysis’ that follows cell membrane damage or cell death, and activation 
of ATP-binding cassette (ABC) transporters in non-neuronal cells (Bodin and Burnstock, 
2001).  Similar to ATP, UTP and other nucleotides can also be released from cells, 
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particularly under conditions of stress. However, the concentration of stored UTP is much 
lower than ATP. For example, UTP is stored in platelet granules at about 10% of ATP 
levels (Anderson and Parkinson, 1997). Extracellular nucleotides are rapidly metabolized 
by a ubiquitous family of membrane-bound enzymes (ecto-enzymes). A variety of 
ecto-ATPases and ecto-nucleotidases work together to hydrolyze NTP into NDP or N, 
NDP into NMP, and NMP into N (Anderson and Parkinson, 1997). Some of these 
metabolized products can also induce cellular responses, similar to ATP and UTP 
(Burnstock, 2002; Burnstock, 2007).  
 
2. P2Y receptors and their physiological functions 
 
Two types of purinoceptors, P1 and P2 receptors, mediate the effects of extracellular 
nucleotides and nucleosides.  P1 receptors are mainly activated by adenosine or 
adenosine-like compounds. So far, four P1 receptor subtypes (A1, A2A, A2B and A3) have 
been cloned (Burnstock, 2007).  The main activating ligands for P2 receptors in vivo are 
extracellular ATP, ADP, UTP and UDP (Burnstock, 2007).  P2 receptors are subdivided 
into two distinct categories, the metabotropic G protein-coupled (P2Y) receptors and the 
ionotropic ligand-gated ion channel (P2X) receptors. To date, 7 P2X and 8 P2Y receptor 
subtypes have been identified by molecular cloning and pharmacological characterization, 
leading to a greater understanding of the diversity of signal transduction pathways 
coupled to P2X and P2Y receptors in different systems.  P2X receptors are ATP-gated 
ion channels that mediate rapid cell membrane depolarization and increase 
transmembrane transport of cations (e.g., Na+, K+, and Ca2+). P2Y receptors for purine 
and pyrimidine nucleotides belong to the superfamily of G protein-coupled receptors 
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(GPCRs) comprised of seven transmembrane domains. Currently, eight mammalian P2Y 
receptor subtypes have been cloned and characterized in heterologous expression systems: 
P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14 receptors (see Table 1).  
Human P2Y receptors consist of 328 (P2Y6) to 377 (P2Y2) amino acids with 
glycosylation sites in the extracellular N-terminal domains. Although all P2Y receptors 
share a seven transmembrane domain tertiary structure, the amino acid sequences, 
pharmacological profiles and signal transduction pathways of these GCPRs vary 
significantly (see Table 1). Using rhodopsin as a template, models of the P2Y1 and P2Y2 
receptor ligand binding sites have been produced that indicate the presence of several 
positively charged amino acids in highly conserved transmembrane regions 3, 6 and 7 
that could act as counterions for the binding of negatively charged nucleotide ligands 
(Van Rhee et al., 1995). Consistent with this conclusion, site-directed mutagenesis of the 
P2Y2 receptor to replace positively charged amino acid residues in transmembrane 
regions 6 and 7 with neutral amino acids produced receptors with dramatically altered 
agonist potencies as compared to the wild type P2Y2 receptor (Erb et al., 1995).  These 
positively charged amino acids are found in domains 6 and 7 of all P2Y receptors cloned 
to date.  
Although the functions of some P2 receptor subtypes may be overlapping and 
therefore redundant under physiological conditions, as suggested by the phenotypes of 
P2Y receptor knockout mice (Cressman et al., 1999; Ghanem et al., 2005), there is 
increasing evidence that specific P2Y receptors in vascular endothelial smooth muscle 
cells and leukocytes are important mediators of thrombosis and vascular inflammation. 
For example, a P2Y1 receptor-null mouse model was used to demonstrate that the lack of 
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P2Y1 receptor expression leads to prolonged bleeding times and resistance to 
ADP-induced thromboembolism (Fabre et al., 1999; Leon et al., 1999), consistent with 
the role of this receptor in the regulation of platelet aggregation in vitro (Kunapuli et al., 
2003). Other studies indicate that a frame-shift mutation in the P2Y12 receptor gene may 
be responsible for a mild bleeding disorder (Hollopeter et al., 2001). Subsequently, the 
role of the P2Y12 receptor in arterial thrombogenesis was confirmed in P2Y12 receptor 
knockout mice that exhibit impaired platelet adhesion to von Willebrand factor (vWF) 
and decreased platelet activity, as indicated by lower fibrinogen-binding, delayed 
thrombus growth and unstable thrombi in injured arteries (Andre et al., 2003). 
ADP-induced activation of ERK1 is inhibited by the P2Y12 and P2Y13 receptor antagonist 
AR-C69931MX in human monocyte-derived dendritic cells, resulting in the inhibition of 
inflammatory cytokine production (Marteau et al., 2004).   
Recently, P2Y6 receptors have been found to act as mediators of phagocytosis in 
microglia (i.e., brain immune cells), by sensing UDP signals (Koizumi et al., 2007).  In 
addition, ATP released at sites of inflammation has been suggested to induce maturation 
of human monocyte-derived dendritic cells (MoDC) via P2Y11 receptor-mediated 
activation of adenylyl cyclase and protein kinase A (Wilkin et al., 2001).  P2Y11 receptor 
activation also inhibits MoDC migration (Schnurr et al., 2003). Correlating with MoDC 
maturation, P2Y11 receptor expression is down-regulated in mature MoDC, whereupon 
ATP becomes a less effective inhibitor of cell migration (Schnurr et al., 2003).  
P2Y14 receptors for UDP-glucose mediate bone marrow hematopoietic stem cell 
chemotaxis induced by UDP-sugars derived from the bone marrow microenvironment, 
suggesting a role for P2Y14 receptor activity in responses to injury in which stem cells 
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provide the basic level of repair (Lee et al., 2003).  UDP-glucose has been shown to 
increase [Ca2+]i in immature human MoDC but not in mature dendritic cells, suggesting a 
role for this receptor in dendritic cell maturation (Skelton et al., 2003). The P2Y14 
receptor is also expressed in the rat brain where its mRNA can be up-regulated by 
immunologic challenge with lipopolysaccharide, suggesting an important role for P2Y14 
receptors in UDP-glucose-induced responses relating to neuroimmune function  (Moore 
et al., 2003). 
 
3. P2Y2 receptor 
P2Y2 receptors have been cloned from human, rat, mouse and porcine cells or tissues 
(Lustig et al., 1993; Parr et al., 1994; Chen et al., 1996; Shen et al., 2004). ATP and UTP 
are equipotent agonists of the P2Y2 receptor, whereas ADP and UDP are less effective 
(Lazarowski et al., 1995). P2Y2 receptor mRNA is expressed in human skeletal muscle, 
heart, brain, spleen, lymphocytes, macrophages, bone marrow and lung, with lower levels 
expressed in liver, stomach and pancreas (Moore et al., 2001).  
P2Y2 receptors stimulate multiple and divergent intracellular signaling pathways that 
mediate a variety of physiological and pathological responses (Fig. 1).  P2Y2 receptors 
couple to both Gi/o and Gq proteins to mediate the activation of phospholipase Cβ, leading 
to the production of inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), second 
messengers for calcium release from intracellular storage sites and protein kinase C (PKC) 
activation, respectively (Weisman et al., 1998). Activation of PKC, in turn, promotes the 
synthesis and/or release of arachidonic acid (AA), prostaglandins, and nitric oxide (NO) 
(Xu et al., 2002, 2003a). In primary murine astrocytes, P2Y2 receptors mediate activation 
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of PKC and ERK1/2, via both calcium-dependent and calcium-independent pathways, 
leading to activation of cytosolic phospholipases A2 and the release of AA (Xu et al., 
2002), the precursor of prostaglandins, eicosanoids, and leukotrienes (Balsinde et al., 
2002). Studies have indicated that P2Y2 receptor-mediated MAPK activation in  C12 
cells is dependent upon transactivation of the EGFR via a Src/adhesion focal tyrosine 
kinase (RAFTK)-dependent pathway (Soltoff et al., 1998).  In addition, P2Y2 receptor 
activation induces p38- and ERK1/2-dependent phosphorylation of the cAMP responsive 
element binding (CREB) protein and up-regulation of anti-apoptotic (i.e., Bcl-2 and 
Bcl-xL) and other neuroprotective genes in human astrocytoma cells (Chorna et al., 2004).  
Other studies indicate that an integrin-binding domain (Arg-Gly-Asp) in the first 
extracellular loop of the P2Y2 receptor mediates its association with αvβ3/β5 integrins, 
enabling the coupling of the P2Y2 receptor to Go but not Gq proteins (Erb et al., 2001).   
Functional analysis revealed that activation of P2Y2 receptors in isolated UTP- or 
ATP-perfused rat hearts induced pronounced vasodilation of blood vessels (Godecke et 
al., 1996), consistent with earlier studies indicating that P2Y2 receptor activation induces 
relaxation of smooth muscle through the endothelium-dependent release of NO and 
prostacyclin (Lustig et al., 1992; Pearson et al., 1992a, 1992b). In smooth muscle cells, 
P2Y2 receptor expression is up-regulated by inflammatory agents, such as transforming 
growth factor (TGF)-β, basic fibroblast growth factor (bFGF), and even ATP (Hou et al., 
1999). Up-regulation of P2Y2 receptors occurs in response to balloon angioplasty (Seye 
et al., 1997) and causes intimal hyperplasia in collared rabbit carotid arteries due to the 
stimulation of smooth muscle cell proliferation and migration (Seye et al., 2002), 
suggesting an important role for P2Y2 receptors in the initiation of atherosclerotic lesion 
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formation. Up-regulation of the P2Y2 receptor also was observed by short-term culture (3 
h to 6 days) of normal rat submandibular gland cells (Turner et al., 1997), and in 
activated mouse thymocytes (Koshiba et al., 1997). P2Y2 receptor activation in astrocytes 
increases the synthesis of arachidonic acid and prostaglandin E2 as well as activation of 
type 2 cyclooxygenase (COX-2), which mediate inflammation and reactive astrogliosis 
associated with neurodegenerative diseases, including Alzheimer’s disease (Brambilla et 
al., 1999; Brambilla and Abbracchio, 2001). In endothelial cells, P2Y2 receptor activation 
causes up-regulation of vascular cell adhesion molecule-1 (VCAM-1) that mediates the 
adherence of monocytes to vascular endothelium (Seye et al., 2003), leading to their 
penetration into the blood vessel wall to promote arterial inflammation associated with 
cardiovascular disease (Seye et al., 2002). Recent studies have revealed that a Src 
homology-3 (SH3) binding domain in the C-terminal tail of the P2Y2 receptor promotes 
the nucleotide-induced association of Src with the P2Y2 receptor, leading to the 
transactivation of growth factor receptors such as the EGF and VEGF receptors (Liu et al., 
2004). Deletion of the SH3 binding domain inhibits P2Y2 receptor-mediated 
transactivation of the EGF and VEGF receptors and nucleotide-induced up-regulation of 
VCAM-1 (Liu et al., 2004; Seye et al., 2004), demonstrating a novel mechanism whereby 
P2Y2 receptors can cause inflammatory responses in blood vessels.  
Nucleotides are released during vascular injury from activated platelets and damaged 
cells (Schwiebert and Kishore, 2001; Oike et al., 2004). Released ATP and UTP can 
activate P2Y2 receptors in human neutrophils to induce fibrinogen-dependent 
degranulation independent of arachidonic acid metabolites (Meshki et al., 2004). A recent 
study suggests that ATP is released from human neutrophils exposed to fMLP 
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(N-formyl-L-methionyl-L-leucyl-L-phenylalanine), a formylated tripeptide secreted by 
bacteria (Chen et al., 2006) and that P2Y2 receptors are required for neutrophils to 
amplify the ATP-induced chemotactic signals that guide the cell to migrate since 
neutrophils from P2Y2–/–mice fail to undergo chemotaxis towards fMLP in vitro and in 
vivo (Chen et al., 2006). In addition, introduction of the P2Y2R agonist UTP via a 
vascular collar placed around a rabbit carotid artery, causes a 4-fold increase in leukocyte 
migration into the intima (Seye et al., 2002). Since leukocyte infiltration and migration 
are key processes involved in atherosclerosis, these findings suggest that P2Y2 receptors 
represent a novel target for reducing arterial inflammation associated with cardiovascular 
disease. 
Activation of the P2Y2 receptor also increases epithelial cell Cl- secretion and inhibits 
Na+ absorption, an effect that has been explored for its potential therapeutic application in 
the treatment of cystic fibrosis, a dehydrating disease characterized by defective Cl- 
secretion due to genetic mutations in CFTR in airway epithelium (Clarke and Boucher, 
1992; Parr et al., 1994; Kellerman et al., 2002).  The role of the P2Y2 receptor in 
regulating ion secretion in airway epithelial cells has been confirmed in P2Y2 receptor 
knockout mice (Cressman et al., 1999). A selective P2Y2 receptor agonist, INS27217, also 
has been shown to increase chloride and water secretion in tracheal epithelium, cilia beat 
frequency and mucin release from human airway epithelium, suggesting potential 
treatments for dry eye disease and cystic fibrosis (Yerxa et al., 2002). Activation of P2Y2 
and other P2 receptors in human keratinocytes has been postulated to play a role in the 
wound healing process (Burrell et al., 2003; Greig et al., 2003a, 2003b). P2Y2 receptors 
also can promote α-secretase-dependent amyloid precursor protein processing in 1321N1 
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astrocytoma cells, suggesting a neuroprotective role (Camden et al., 2005). In contrast to 
these therapeutic effects, P2Y2 receptors in osteoblasts function as negative modulators of 
bone remodeling by blocking bone formation by osteoblasts (Hoebertz et al., 2002).  
Thus, depending upon the tissue, P2Y2 receptor expression and activation can promote 
deleterious (e.g., endothelium, smooth muscle and bone) or beneficial (e.g., epithelium 
and neuron) responses, which makes the P2Y2 receptor a potential pharmacological target 
in atherosclerosis, inflammation, cystic fibrosis, osteoporosis, and neurodegenerative 
disorders. 
 
D. Chemotaxis 
Chemotaxis is the movement of a cell in response to a chemical gradient. In bacteria, 
chemotaxis is important for finding food (e.g., glucose) by swimming towards the highest 
concentration of food molecules, or fleeing from poisons, such as phenol. In eukaryotes, 
the mechanism of chemotaxis is quite different from that in bacteria; however, sensing of 
chemical gradients by cell surface receptors is still a crucial step in this process.  In the 
mammalian system, chemotaxis is required for many important processes, including 
embryonic development, angiogenesis, inflammatory responses and cancer cell 
metastasis (Li et al., 2005). In the process of inflammation, chemotaxis is a key step in 
leukocyte recruitment. 
 
1.  P2Y receptors and chemotaxis 
   P2Y receptors are able to induce chemotaxis in a variety of cell types, including 
smooth muscle cells (Pillois et al., 2002), epithelial cells (Klepeis et al., 2004), 
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endothelial cells (Kaczmarek et al., 2005), microglia (Honda et al., 2001), astrocytes 
(Wang et al., 2005), neutrophils (Chen et al., 2006), and bone marrow hematopoietic 
stem cells (Lee et al., 2003). 
    In rat aortic smooth muscle cells (rASMC), ATP, UTP and UDP, but not ADP, 
induce chemotaxis, suggesting involvement of P2Y2 and P2Y6 receptors (Pillois et al., 
2002). UTP treatment causes a dose-dependent up-regulation of osteopontin, a ligand for 
αvβ3 integrins (Chaulet et al., 2001). UTP-induced ASMC migration is dependent on the 
expression of osteopotin via a pathway that involves Rho (a small GTPase responsible for 
cell morphological changes) and MAPK (Chaulet et al., 2001).  Similarly, ATP and 
UTP, but not ADP, induce migration of human umbilical vein endothelial cells (HUVEC), 
a process associated with up-regulation of αv integrins that requires activation of PI3K 
and focal adhesion kinase (Kaczmarek et al., 2005). 
    Actin cytoskeletal rearrangements have been seen in both smooth muscle cells and 
endothelial cells stimulated with extracellular nucleotides (Sauzeau et al., 2000;  
Kaczmarek et al., 2005). Studies indicate that P2Y1, P2Y2, P2Y4 and P2Y6 receptors are 
coupled to activation of RhoA (Sauzeau et al., 2000), although the P2Y1 receptor is not 
thought to be involved in the migration of ASMC and endothelial cells since ADP does 
not have chemoattractant effects in these cells (Pillois et al., 2002; Kaczmarek et al., 
2005). However, MRS-2179, a selective P2Y1 receptor antagonist, reduced the rate of 
migration of wild type mouse neural progenitor cells, suggesting the involvement of 
P2Y1 receptors in neural development. Furthermore, knockout of connexin 43, a tight 
junction protein implicated in the release of ATP from neutrophils (Eltzschig et al., 2006),  
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down-regulates the migratory ability of neural progenitor cells, an event that can be 
restored by exogenous expression of P2Y1 receptors (Scemes et al., 2003).  
    Chen et al. showed that ATP is released from the protrusion region during neutrophil 
migration toward fMLP, a chemoattractant peptide secreted by certain pathogens (Chen 
et al., 2006). Due to the presence of ecto-nucleotidases, such as CD39 and CD73, in 
plasma membranes, ATP and ADP are converted into AMP, which is further hydrolyzed 
to adenosine. Chen et al. found that A3 adenosine receptors, but not P2Y2 receptors, 
accumulate at the leading edge of migrating neutrophils exposed to a fMLP gradient and 
co-localized with F-actin-containing protrusions.  A3 adenosine receptor-null cells 
perform normal directional sensing toward fMLP, but migrate at a much reduced speed 
than wild type cells, whereas P2Y2 receptor-null cells have an impaired ability to sense 
the fMLP gradient. These findings suggest a model of coordinated purinergic signaling to 
achieve proper neutrophil chemotaxis during inflammation. Consistent with these data, 
CD39-null monocytes/macrophages fail to migrate into implanted Matrigel in vivo or 
towards nucleotides in vitro, indicating a possible role for nucleotides and nucleotide 
receptors in monocyte migration during inflammation (Goepfert et al., 2001). 
 
2. Chemotaxis and GPCRs 
Mammalian neutrophils and the amoeba Dictyoselium are two models frequently 
used to study the molecular mechanisms of chemotaxis. Chemotaxis requires a 
complicated coordination and integration of a series of biochemical signals. External 
signals for a cell to migrate include soluble chemoattractant, extracellular matrix proteins 
and mechanical stress. Cell surface receptors, most of which are heterotrimeric GPCRs, 
can sense a gradient of chemoattractants that has concentration differences as little as 
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1~2% (Zigmond, 1977; Tranquillo et al., 1988). Two characteristics contributing to 
chemotaxis are directional sensing and morphological polarization (Swanson and Taylor, 
1982; Fisher et al., 1989; Parent and Devreotes, 1999).  In response to chemokines, 
GPCRs activate GDP to GTP exchange on the Gα subunit and promote the dissociation 
between the Gα and Gβγ subunits, leading to the activation of downstream effectors. To 
date, four families of mammalian heterotrimeric G proteins have been identified 
according to their different α subunits: Gαq/11, Gαs, Gαi/o, Gα12/13 (Offermanns, 2003). 
Most of the mammalian chemotactic GPCRs are coupled to Gαi/o, since pertussis toxin, a 
specific Gαi/o inhibitor prevents chemotaxis and many other responses to ligands of 
chemokine receptors (Gerard and Gerard, 1994), whereas some cells such as neutrophils 
utilize Gα12/13, as well as Gαi/o, to assemble divergent signaling complexes and to adopt 
an appropriate morphology in the presence of chemoattractants (Xu et al., 2003b).  
Expression of two Gβγ subunit-sequestering proteins, a C-terminal fragment of the 
β-adrenoreceptor kinase or the α subunit of transducin (αt), inhibits Gi-mediated 
chemotaxis, suggesting an important role of the released Gβγ dimer in chemotaxis (Arai 
et al., 1997; Neptune and Bourne, 1997).  In living cells during chemotaxis, Gβ subunits 
are mainly localized at the anterior end, whereas some chemoattractant receptors are 
evenly distributed along the surface of polarized cells (Servant et al., 1999; Jin et al., 
2000).   In fact, the agonist-induced release of Gβγ subunits from receptors leads to 
activation of phosphatidylinositol-3 kinase (PI3K) γ (Stephens et al., 1994). Studies with 
PI3Kγ knockout mice reveal an important role of PI3Kγ in chemoattractant-induced 
macrophage migration (Hirsch et al., 2000). The PI3K substrate PIP3 and pleckstrin 
homology (PH) domain-containing proteins (such as Akt/PKB and adenylyl cyclase) are 
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found to be enriched at the leading edge of migrating cells following a chemoattractant 
gradient (Jin et al., 2000; Servant et al., 2000). Although inhibition of actin 
polymerization causes the lost of cell polarity and asymmetric distribution of 
Gβ subunits, it does not affect the recruitment of PH domain-containing proteins to the 
leading edge, suggesting that the polarized distribution of Gβ subunits depends on 
intrinsic signals whereas the appearance of PH domain binding sites indicates the 
direction of movement (Jin et al., 2000; Servant et al., 2000).  
 
3. Rho GTPases 
Rho GTPases, a family of small monomeric GTPases, are also crucial for controlling 
directed cell migration. The Rho family is divided into three subgroups: Rac, Rho and 
Cdc42. To date, twenty two mammalian genes encoding Rho GTPases have been 
described (Jaffe and Hall, 2005). Similar to other GTPases, Rho GTPases cycle between 
the inactive GDP-bound state and the active GTP-bound state. Three major groups of 
regulatory proteins control Rho GTPase activities: GEFs (guanine nucleotide exchange 
factors) that catalyze the exchange of GDP for GTP, GAPs (GTPase-activating proteins) 
that promote intrinsic GTPase activity to inactivate the protein, and GDIs (guanine 
nucleotide dissociation inhibitors) that block Rho GTPase self-activation (Jaffe and Hall, 
2005).  Different Rho GTPases have differential roles in regulating the morphology of a 
migrating cell. Generally, Rho-like family proteins are responsible for formation of stress 
fibers and focal adhesions, providing the cell with contractility; Rac-like family proteins 
promote the formation of membrane ruffles and lamellipodia; and Cdc42-like family 
proteins simulate the formation of filopodia (Burridge and Wennerberg, 2004). Actin 
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polymerization and actin/myosin contraction as well as filament elongation at the leading 
edge of cells are thought to provide the driving force for migration. Rho stimulates actin 
polymerization via the diaphanous-related formin (DRF), mDia1 in mammalian cells. 
mDia1 directly interacts with the profilin/actin complex and sends it to a filament end. 
Rho also induces assembly of contractile actin/myosin filaments via its target 
Rho-associated kinase (ROCK), leading to activation of LIM kinase (LIMK). LIMK 
promotes phosphorylation-induced inactivation of cofilin, which participates in actin 
filament disassembly by increasing actin monomer dissociation, leading to stabilization 
of the actin cytoskeleton. LIMK also inactivates myosin light chain (MLC) phosphatase 
by phosphorylation. This, in turn, increases MLC phosphorylation and stimulates the 
actin filament cross-linking activity of myosin II (Pollard and Borisy, 2003; Riento and 
Ridley, 2003; Jaffe and Hall, 2005).  
Rho GTPases are also involved in directional sensing. For example, general inhibitor 
of Rho GTPases blocks the chemoattractant-induced translocation of PH 
domain-containing proteins, induces a round cell morphology and inhibits actin 
polymerization in response to a chemoattractant (Servant et al., 2000). Inhibition of Rac 
by overexpression of dominant-negative mutants in neutrophils blocks 
chemoattractant-induced actin polymerization, translocation of PH-domain containing 
proteins, and thus cell polarity, while inhibition of Cdc42 induces multiple leading edges 
instead of the normal formation of one leading front (Srinivasan et al., 2003). Both Rho 
and Rac are required for colony stimulating factor-1-induced macrophage migration, 
however, inhibition of Cdc42 prevents chemotaxis but keeps cell random migration intact, 
suggesting that Cdc42 is important for gradient sensing (Allen et al., 1998). It is likely 
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that different Rho GTPases are differentially regulated by different receptors/G proteins 
in separate spatial domains during chemotaxis. Gi/o triggers the activation of Rac and 
mediates the formation of protrusions at the leading edge of a cell; G12/13 promotes the 
activation of Rho and induces polarized actin reorganization at the rear of a cell to 
provide the rendering force (Xu et al., 2003b).  
 
4. Regulation of chemotaxis by integrins and the extracellular matrix (ECM) 
Cell motility requires the forward movement of the leading edge of a cell by 
extension, formation of adhesive contacts in these extensions and detachment of old 
adhesive contacts in the trailing edge (Ridley et al., 2003). Adhesion is mainly mediated 
by integrins, which are heterodimeric receptors consisting of α and β subunits with large 
extracellular domains and relatively short cytoplasmic domains. Integrins bind 
extracellular matrix (ECM) proteins and intracellular cytoskeletal proteins, thus linking 
signaling from the outside to the inside of cells (Hynes, 1992). Many of the integrins 
have been shown to play a role in cell migration. For example, αvβ3 integrins are found to 
play a key role in cell migration during angiogenesis (Brooks et al., 1994) and metastasis 
(Seftor et al., 1992); β3 and β2 integrins are found to be crucial for immune cell migration 
( Springer, 1995; Lacy-Hulbert et al., 2007).  
The ECM, which consists of proteins that act as ligands for integrins, is able to 
regulate the speed and direction of chemotaxis by controlling integrin-ECM interactions 
and adhesion formation. At low levels of ECM, the cells can not form stable adhesions 
where integrins serve as contact sites to generate tractional forces that are transmitted 
from the interaction of myosin II and actin filaments. At high levels of ECM, the cell can 
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not break the integrin-ECM interactions at the rear of the cell and therefore can not move 
forward. Thus, integrin-mediated migration is dependent on the cell surface density of 
integrins, the density of ligands (ECM), and the affinity between integrin and ECM 
( Ridley et al., 2003; Li et al., 2005). 
Although integrins lack any catalytic activities, they do transmit signals by direct or 
indirect interactions with other proteins. For example, the cytoplasmic domain of the α4 
integrin subunit interacts with a signaling adaptor protein, paxillin. This interaction is 
critical for effective α4β1-dependent leukocyte migration (Rose, 2006). Talin, another 
cytoskeletal protein, binds to several β integrins and its head domain is responsible for 
activation of αIIbβ3 and αLβ2 integrins (Calderwood et al., 2002; Kim et al., 2003). 
Activated αvβ3/5 integrins, detected by the engineered antibody WOW-1, are found 
preferentially distributed to lamellipodia at the leading edge of a migrating cell (Kiosses 
et al., 2001). Pre-incubation with WOW-1 antibody blocks endothelial chemotaxis on 
fibrinogen (a ligand for αvβ3 integrins) towards bFGF (basic fibroblast growth factor), 
suggesting a role for high affinity integrins in chemotaxis (Kiosses et al., 2001). Integrin 
function is also regulated by post-translational modification. For example, 
phosphorylated  α4 integrins (on serine residues) are also found to accumulate in 
lamellipodia, and α4 integrin phosphorylation and subsequent release of bound paxillin 
are thought to be required for  α4β1-dependent cell migration and lamellipodia stability 
(Goldfinger et al., 2003).  
By participating in outside-in signaling, integrins can modulate the activities of Rho 
GTPases and other signaling molecules at focal adhesions to regulate cell migration. 
Cells plated on fibronectin exhibit a rapid activation of Rac and Cdc42 and spread by 
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forming filopodia and lamellipodia (Price et al., 1998). In contrast, Rho activity decreases 
initially when cells are plated on ECM proteins, followed by a transient peak of 
activation, which then returns to baseline (Ren et al., 1999), suggesting that Rho GTPase 
activity can be differentially modulated by integrin dynamics. Consistent with these 
observations, studies with fibroblasts indicate that ROCK inhibitor increases 
lysophosphatidic acid (LPA)-induced Rac activation (Tsuji et al., 2002). These signals 
are thought to be able to coordinate with each other during cell migration by a feedback 
loop, driving fluctuations in Rho and Rac activities to maintain cell polarity (Moissoglu 
and Schwartz, 2006).  
Integrins can modulate other receptor functions by either direct association of the 
receptors or transactivation between receptors. For example, αvβ3 integrin is found to 
associate with activated platelet-derived growth factor receptor (PDGFR) and vascular 
endothelial growth factor receptor-2 (VEGFR-2), to play a synergistic role in growth 
factor-induced mitogenicity or cell migration (Schneller et al., 1997; Woodard et al., 
1998; Soldi et al., 1999).  
 
E. Cell-cell adherens junction proteins and Rho GTPases 
    Cell-cell adhesion is believed to support stability of normal tissue organizations in 
embryonic development. Major components of cell-cell adherens junctions include 
cadherins, a family of transmembrane proteins that form dimers with other cadherin 
molecules on adjacent cells, and catenins, a family of proteins that bind to cadherin’s 
intracellular domain and serve as a connection between cadherins and actin cytoskelelton 
(Braga, 2002). Classic cadherins have a wide range of distribution. E-cadherin is found 
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mainly in epithelial cell junctions and P-cadherins are found in squamous epithelial cells, 
whereas fibroblasts express N-cadherin in cell-cell junctions and VE-cadherin expression 
is restricted to vascular endothelial cells (Angst et al., 2001). There is evidence that Rho 
GTPases regulate cadherin functions as inside-out signals and cadherins regulate Rho 
GTPase activities as outside-in signals. Rac activation induces increased E-cadherin and 
β-catenin distribution at cell-cell adhesion sites (Takaishi et al., 1997), whereas Rho has 
dual functions, either via ROCK to disrupt adherens junctions or via mDia to stabilize 
them (Sahai and Marshall, 2002). As an example of outside-in signaling, engagement of 
epithelial-like cadherins increases the activity of Rac and Cdc42, but inhibits Rho 
activation (Noren et al., 2001). Time-lapse microscopy shows that GFP-tagged Rac1 
accumulates at the nascent contact membranes along the leading edges of 
cadherin-containing lamellipodia when migratory cells collide or in the presence of 
E-cadherin homopilic engagement (Ehrlich et al., 2002; Kovacs et al., 2002). Clustering 
of E-cadherin by mouse anti-cadherin antibody and anti-mouse IgG leads to activation of 
Rac1 in keratinocytes, an event dependent on epidermal growth factor receptor (EGFR) 
signaling (Betson et al., 2002). VE-cadherin, a unique adherens junction protein in 
endothelial cells, is found to be responsible for activation of Rac1, but not RhoA, 
probably due to the increased expression and membrane localization of the Rac1 GEF, 
Tiam 1, in VE-cadherin-expressing cells (Lampugnani et al., 2002).  In contrast, 
N-cadherin engagement results in activation of RhoA, but not Rac1 or Cdc42 (Charrasse 
et al., 2002).  Transfection with E-cadherin inhibits invasive carcinoma cell motility, 
and cell motility can again be induced by treatment with anti-E-cadherin antibodies, 
suggesting an inhibitory role for E-cadherin in cell motility (Frixen et al., 1991). 
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However, inappropriate expression of a non-epithelial cadherin such as N-cadherin or 
R-cadherin (retinal cadherin), which activate Rac and Cdc42, induces cell motility 
(Nieman et al., 1999; Johnson et al., 2004), suggesting that diverse cellular functions are 
probably regulated by cadherins. 
    How do cadherins regulate the activity of small Rho GTPase? One connection 
between cadherins and Rho GTPases is p120 catenin. It has been shown that cytosolic 
p120 catenin inhibits the activation of RhoA, but not Rac and Cdc42, probably via 
interacting with the Rho GTPase GEF, vav2 (Noren et al., 2000). In addition, Gα12 
family proteins have negative effects on E-cadherin-mediated inhibition of cell migration 
in a Rho-independent manner (Meigs et al., 2002), possibly because Gα12/13 proteins 
interact with p120 catenin and overcome the inhibition of RhoA activity by p120 catenin 
(Krakstad et al., 2004). Alternatively, PI3K-dependent and EGFR-dependent intrinsic 
signaling might be involved in Rho GTPase regulation by cadherins (Betson et al., 2002; 
Kovacs et al., 2002). 
 
F. Research goals and experimental approaches 
There is increasing evidence that the P2Y2R plays an important role in the 
development of vascular inflammation. For example, UTP, the agonist for the P2Y2R, 
increases neutrophil infiltration into the neointima (Seye et al., 2002). Furthermore, 
P2Y2R knockout mice are unable to recruit neutrophils into the sites of injury or bacterial 
infection (Chen et al., 2006). The central research goal of this dissertation is to explore 
the mechanisms of P2Y2R-mediated inflammatory responses including leukocyte 
chemotaxis and endothelium-dependent leukocyte transendothelial migration. Since the 
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small Rho GTPases control these cellular processes via regulation of actin dynamics, one 
of the major aims of this dissertation is to examine the mechanisms involved in 
P2Y2R-mediated activation of these Rho GTPases in different cells. Structure-function 
analysis reveals that the human P2Y2R contains an extracellular αv integrin binding 
domain as well as a C-terminal SH3-binding domain. We, therefore, studied the role of 
these functional domains in P2Y2R-mediated activation of Rho GTPases in 1312N1 
human astrocytoma cells that do not express any endogenous P2 receptors by using cells 
that are stably transfected with wild type or mutant P2Y2Rs. We also used pharmaceutical 
compounds or small interference RNA to block specific protein functions to further 
delineate the mechanisms of P2Y2R-mediated activation of Rho GTPase in cells 
endogenously expressing the P2Y2R (i.e., endothelial cells). 
The experimental results of this dissertation are divided into the following chapters, 
according to their specific research aims: 
1. Chapter II ─ determines the role of the P2Y2R/αv integrin interaction in 
P2Y2R-mediated cell cytoskeletal rearrangements and delineates the signaling 
pathways involved in this process. 
2. Chapter III ─ determines the role of the P2Y2R/αv integrin interaction in 
P2Y2R-mediated cell chemotaxis and delineates the mechanisms involved. 
3. Chapter IV ─ explores the crosstalk between the P2Y2R and adherens junction 
proteins in endothelial cells and examines the role of adherens junction proteins in 
P2Y2R-mediated activation of Rho GTPases. 
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Table I-1. Cloned P2Y receptor subtypes and pharmacology  
Lambrecht et al., 1992; Lustig et al., 1993; Parr et al., 1994; Chang et al., 1995; 
Communi et al., 1995; Lazarowski et al., 1995; Nguyen et al., 1995; Tokuyama et al., 
1995; Ayyanathan et al., 1996; Boyer et al., 1996; Charlton et al., 1996; Chen et al., 1996; 
Communi et al.,1996; Communi et al., 1997; Robaye et al., 1997; Bogdanov et al., 1998; 
Palmer et al., 1998; Communi et al., 1999; Ingall et al., 1999; Chambers et al., 2000; 
Communi et al., 2001; Freeman et al., 2001; Hollopeter et al., 2001; Lazarowski et al., 
2001; Zhang et al., 2001; Zhang et al., 2002; Abbracchio et al., 2003; Marteau et al., 2003; 
Fumagalli et al., 2004; Shen et al., 2004. 
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Table 1 
 Receptor 
 subtypes 
species 
cloned 
agonists antagonists Transduction 
Mechanisms 
P2Y1 human, 
rat, mouse 
2MeSADP > 
ADP > ATP 
A3P5PS, PPADS, 
suramin 
Gq/11, PLC activation 
P2Y2 human, 
rat, 
mouse, 
porcine 
UTP >= ATP 
> 5BrUTP  
suramin Gq/11, PLC activation; 
 Gi/o, PLC activation; 
G12, Rho activation 
P2Y4 human, 
rat, mouse 
UTP > ATP PPADS Gq/11 and Gi/o, PLC 
activation 
P2Y6 human, 
rat, mouse 
UDP > UTP 
> ADP 
PPADS, suramin Gq/11, PLC activation 
P2Y11 human ATPγS > 
BzATP > 
ATP 
suramin Gq/11 and Gs, PLC 
activation 
P2Y12 human, 
rat, mouse 
2MeSATP = 
2MeSADP > 
ADP 
suramin, 
AR-C6096, 
AR-C69931MX 
Gi/o, inhibition of 
adenylate cyclase; 
possibly G12 
P2Y13 human, 
rat, mouse 
2MeSATP = 
2MeSADP > 
ADP > ATP 
AR-C69931MX, 
PPADS,suramin 
Gi/o, inhibition of 
adenylate cyclase; 
P2Y14 human, 
rat, mouse 
UDP-glucose 
> UDP- 
galactose 
not defined Gq/11, PLC activation 
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Figure. I-1  Intracellular signaling pathways activated by the P2Y2 receptor (Erb et al., 
2006). Responses to P2Y2 receptor activation in different cell types may vary, possibly due 
to crosstalk occurring between different signaling pathways and to differential expression 
of cell-specific effector proteins. This diagram represents the divergent and comprehensive 
signaling events mediated by the P2Y2 receptor. Arrows with solid lines show established 
responses mediated by the P2Y2 receptor, whereas, dashed lines show established signaling 
pathways that have not yet been studied for P2Y2 receptors. AA arachidonic acid, ADAM a 
disintegrin and metalloproteinase, APP amyloid precursor protein, CaM calmodulin, CaMK 
calmodulin-dependent protein kinase, CDCC calcium-dependent chloride channel, cGMP 
cyclic GMP, cPLA2 cytosolic phospholipase A2, CREB cAMP response element-binding 
protein, DAG diacylglycerol, ELK-1 ETS-domain transcription factor, ERK extracellular 
signal-regulated protein kinase, GC guanylyl cyclase, GIRK G protein-activated inward 
rectifier, GFR growth factor receptor, Grb2 growth factor receptor bound protein 2, IP3 
inositol-1,4,5-trisphosphate, JNK c-Jun N-terminal kinase, MAP4K MAPK kinase kinase 
kinase, MAP3K MAPK kinase kinase, MKK MAPK kinase, MEK mitogen/extracellular 
signal-regulated protein kinase, NF-κB nuclear factor-κB, NO nitric oxide, NOS nitric 
oxide synthase, p38 mitogen-activated protein-serine kinase p38, p90RSK p90 ribosomal 
S6 kinases, PAK p21-activated serine kinase, PGE2 prostaglandin E2, PI3K 
phosphatidylinositol 3-kinase, PIP3 phosphatidyl-3,4,5-triphosphate, PKB protein kinase B, 
PKC protein kinase C, PLCγ phospholipase Cγ, PXXP proline-rich Src homology 3 domain, 
Pyk2 proline-rich tyrosine kinase, RGD Arg-Gly-Asp integrin binding domain, sAPPα 
α-secretase-dependent amyloid precursor protein, Rho, Rac, Ras, Raf monomeric (small) G 
proteins, Shc Src-homology collagen protein, TNF-α tumor necrosis factor-α. 
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CHAPTER II 
The P2Y2 nucleotide receptor requires interaction with αV integrins to 
access and activate G12 
 
Abstract 
The P2Y2 nucleotide receptor (P2Y2R) interacts with αv integrins to activate Go and 
induce chemotaxis in human 1321N1 astrocytoma cells.  In this study, it was determined 
that the P2Y2R also requires interaction with αv integrins to activate G12 and associated 
signaling pathways that control chemotaxis in 1321N1 cells.  Mutation of the 
Arg-Gly-Asp (RGD) integrin-binding sequence in the first extracellular loop of the human 
P2Y2R to Arg-Gly-Glu (RGE), which prevents integrin interaction, did not inhibit Gq or 
ERK1/2 signaling by the P2Y2R agonist UTP but completely inhibited activation of G12 
and G12-mediated events, including Rho activation, cofilin and myosin light chain-2 
phosphorylation, stress fiber formation and chemotaxis towards UTP.  The involvement 
of G12 in all these events was verified by using a dominant negative Gα12 construct.  G12 
activation by the P2Y2R also was inhibited by anti-αvβ5 integrin antibodies and αv integrin 
antisense oligonucleotides, suggesting that αv integrin activity and expression are required 
for the P2Y2R to activate G12.  Co-immunoprecipitation experiments confirmed that Gα12 
protein associates with the wild type P2Y2R and with αv integrins but not with the RGE 
mutant P2Y2R or with α3 integrins.  Collectively, these results suggest that αv integrin 
complexes provide the P2Y2R with access to G12, thereby allowing activation of this 
heterotrimeric G protein that controls actin cytoskeletal rearrangements required for 
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chemotaxis. 
 
Introduction  
 Chemotaxis is the movement of a cell towards a chemoattractant or away from a 
chemorepellant and is a fundamental feature of eukaryotic cells; it is important for many 
physiological and pathological processes, such as embryogenesis, neurogenesis, 
angiogenesis, wound healing, and homing of leukocytes to a site of infection.  The 
ability of a cell to undergo chemotaxis requires the cell to assume a polarized 
morphology that is controlled by cell surface receptors that activate the Rho family of 
small GTPases including Cdc42, Rac, and Rho (Burridge and Wennerberg, 2004).  
Upon activation of a chemoattractant receptor, Cdc42 and Rac localize at the leading 
edge of a cell and control directional cell movement and the formation of a 
lamellipodium, respectively (Burridge and Wennerberg, 2004).  Rho localizes at the rear 
and sides of a cell and controls the formation of contractile actin-myosin stress fibers (Xu 
et al., 2003b).  Together, these GTPases promote cell migration towards a 
chemoattractant by mediating extension of the actin cytoskeleton at the front edge of the 
cell and retraction of the cytoskeleton at the rear.   
 A variety of compounds can act as chemoattractants by stimulating Rho family 
GTPases:  these include growth factors that activate tyrosine kinase receptors, 
extracellular matrix proteins that activate integrins, and compounds that activate certain 
G protein-coupled receptors (GPCRs) (Burridge and Wennerberg, 2004).  Recent studies 
have shown that GPCRs activate Rac and Rac-dependent lamellipodia formation through 
Gi/o, whereas the activity of Rho and Rho-dependent stress fiber formation is controlled 
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by G12/13 (Hart et al., 1998; Kozasa et al., 1998; Xu et al., 2003b).  Furthermore, studies 
have shown that the βγ subunits of Gi/o are responsible for activation of Rac guanine 
nucleotide exchange factors (RacGEFs) that, in turn, activate Rac, whereas the α subunits 
of G12/13 are responsible for activation of RhoGEFs (Neptune et al., 1999; Welch et al., 
2002). 
 In this study, we examined the mechanism of Rho activation and Rho-dependent 
stress fiber formation mediated by the P2Y2 nucleotide receptor (P2Y2R), an 
integrin-associated GPCR activated by ATP or UTP that mediates stress fiber formation 
and chemotaxis in a variety of cell types (Satterwhite et al., 1999; Sauzeau et al., 2000; 
Bagchi et al., 2005; Kaczmarek et al., 2005; Wang et al., 2005) and plays an important 
role in monocyte (Seye et al., 2002) and neutrophil homing (Chen et al., 2006) to injured 
or infected tissues.  Previously, we found that an RGD integrin-binding domain in the 
first extracellular loop of the P2Y2R enables the receptor to interact with αvβ3 and αvβ5 
integrins and this interaction is prevented by mutation of the RGD sequence to RGE (Erb 
et al., 2001).  The RGD domain also was found to be necessary for coupling of the 
P2Y2R to Go-mediated but not Gq-mediated calcium signaling (Erb et al., 2001) and a 
recent study by our group indicated that the P2Y2R requires interaction with αv integrins 
to activate Go and to initiate Go-mediated events, including activation of Rac and the 
RacGEF vav2, up-regulation of vitronectin expression and increased cell migration 
(Bagchi et al., 2005).  Here we report that αv integrin interaction is required for the 
P2Y2R to access and activate G12, leading to Rho activation and Rho-dependent stress 
fiber formation. 
 
33 
 
Results 
P2Y2R-mediated Rho activation and stress fiber formation require interaction with αvβ5 
integrin  
 To determine whether integrin interaction with the P2Y2R is important for 
receptor signaling we mutated the Arg95-Gly96-Asp97 (RGD) sequence in the P2Y2R to 
Arg95-Gly96-Glu97 (RGE), a sequence that does not have high affinity for integrins (Erb et 
al., 2001), and compared signaling events mediated by the wild type and RGE mutant 
receptors that were expressed in human 1321N1 astrocytoma cells.   These cells are 
devoid of endogenous G protein-coupled P2Y receptors (Parr et al., 1994) and, thus, 
provide a suitable null background for this study.  Also, we incorporated a 
hemagglutinin (HA) epitope tag at the C-termini of the wild type and RGE mutant 
P2Y2Rs and used flow cytometry to verify that the cell surface expression levels of these 
receptor constructs were equivalent (Fig. II-1A).  We found that mutation of the RGD 
sequence to RGE did not prevent ERK1/2 phosphorylation in response to the P2Y2R 
agonist UTP (Fig. II-1B) but completely prevented Rho activation (Fig. II-1B) and stress 
fiber formation (Fig. II-1C) induced by UTP at all concentrations tested (100 nM to 2 
mM).   A UTP dose-response curve indicated that the EC50 value for UTP-induced Rho 
activation by the wild type P2Y2R was ~1 µΜ (Supplemental Fig. II-S1), which is similar 
to the EC50 value of UTP for activation of other P2Y2R-mediated responses (Erb et al., 
2001).  These results suggest that integrin interaction with the P2Y2R, via the RGD 
integrin-binding domain, is necessary for the P2Y2R to activate Rho and cause stress 
fiber formation.  Likewise, Rac activation and chemotaxis mediated by the P2Y2R in 
1321N1 cell transfectants were found to require expression of the RGD integrin-binding 
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domain in the P2Y2R (Bagchi et al., 2005). As expected, untransfected 1321N1 cells that 
do not express P2Y receptors do not form stress fibers, undergo chemotaxis, or exhibit 
Rho or Rac activation in response to the P2Y2R agonists ATP or UTP (data not shown).  
 We have found that the RGE mutant P2Y2R can fully stimulate ERK1/2 
phosphorylation (Fig. II-1B) and Gq-mediated calcium signaling (Erb et al., 2001), 
however, these responses require agonist concentrations that are 3 orders of magnitude 
higher than for the wild type receptor.  This has raised questions as to whether the RGE 
mutation affects P2Y2R signaling by preventing integrin interaction or by affecting 
P2Y2R agonist binding affinity.  For example, a recent study by Qi et al. confirmed that 
mutation of the RGD sequence to RGE in the P2Y2R decreases agonist potency for 
inositol phosphate formation by 1000-fold but mutation of the RGD sequence to AHN 
did not alter agonist potency, leading the authors to speculate that the RGD to RGE 
mutation was affecting agonist binding affinity (Qi et al., 2005).  To verify that the loss 
of Rho signaling observed for the P2Y2R RGE mutant was due to decreased integrin 
binding and not to alteration in agonist binding affinity we constructed a P2Y2R mutant 
in which the entire RGD integrin-binding sequence was substituted with three alanines 
(AAA). We found that the AAA mutant P2Y2R had a similar UTP dose-response for 
ERK1/2 phosphorylation as the wild type receptor (Fig. II-2A) but was unable to activate 
Rho in response to UTP (Fig II-2B).  Interestingly, 1321N1 cells expressing the AAA 
mutant did display a higher basal level of ERK1/2 phosphorylation and Rho activity as 
compared to cells expressing the wild type P2Y2R (Figs. II-2A and II-2B).  The reason 
for the increased basal activity exhibited by the AAA mutant is unknown, nonetheless, 
these studies support the hypothesis that integrin interaction via the RGD domain of the 
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P2Y2R is important for controlling Rho activation by the P2Y2R.   
 To further assess the role of P2Y2R-integrin interaction in UTP-induced Rho 
activation and stress fiber formation mediated by the wild type P2Y2R, we used function 
blocking antibodies directed against αvβ5, an integrin that interacts with the P2Y2R, or 
 α3, an integrin that does not interact with the P2Y2R (Erb et al., 2001). Flow cytometry 
experiments indicate that 1321N1 cells express immunodetectable cell surface αV,  α3 
and β5 integrin subunits, but not β3  (Bagchi et al., 2005).  Pretreatment of 
P2Y2R-expressing cells with anti-αvβ5 integrin antibodies inhibited UTP-induced Rho 
activation (Fig. II-3A) and stress fiber formation (Fig. II-3B), whereas anti-α3 integrin 
antibodies had no effect (Figs. II-3A and II-3B), suggesting that αv integrin activity is 
important for P2Y2R-mediated Rho activation and stress fiber formation. In contrast, 
anti-αvβ5 integrin antibodies did not inhibit Rho activation induced by fetal bovine serum 
(FBS) in 1321N1 cells (Supplemental Fig. II-S2), suggesting that αv integrins are not 
involved in Rho activation by growth factors present in serum.   
 
Integrin/P2Y2R interaction regulates Rho-dependent signaling  
 Activation of Rho leads to stress fiber formation by causing the phosphorylation 
of myosin light chain-2 (MLC-2) and cofilin, an actin depolymerizing protein that is 
inhibited when phosphorylated on Ser3 (Kimura et al., 1996; Kuhn et al., 2000). To verify 
that integrin/P2Y2R interaction is important for Rho signaling, we analyzed 
Rho-dependent signaling events in 1321N1 cells expressing the wild type P2Y2R or RGE 
mutant.  UTP caused a dose-dependent increase in phosphorylation of MLC-2 (Fig. 
II-4A) and cofilin (Fig. II-4B) in cells expressing the wild type P2Y2R but not in cells 
36 
 
expressing the RGE mutant.  Moreover, cofilin phosphorylation mediated by the wild 
type P2Y2R was inhibited by pretreatment of the cells with anti-αvβ5 antibodies but not 
anti-α3 integrin antibodies (Fig. II-4C), further demonstrating that the P2Y2R interacts 
selectively with αv  integrins to activate Rho-mediated signaling events.  Since cofilin 
phosphorylation can be regulated by proteins other than Rho, including Rac and testicular 
protein kinase 1 (Toshima et al., 2001; Burridge and Wennerberg, 2004), we used the 
ROCK-Rho pathway inhibitor Y-27632 to determine whether cofilin phosphorylation 
mediated by the P2Y2R occurs through the Rho signaling pathway. UTP-induced cofilin 
phosphorylation was completely inhibited when the cells were pretreated with Y-27632 
(Fig. II-4D).  Furthermore, pretreatment of the cells with the Gi/o inhibitor pertussis 
toxin (PTX) did not inhibit UTP-induced cofilin phosphorylation (Fig. II-4D) but did 
inhibit UTP-induced Rac activation (Bagchi et al., 2005), suggesting that Go-mediated 
activation of Rac is not involved in cofilin phosphorylation by the P2Y2R. 
 
Activation of Gα12 by the P2Y2R requires interaction with αv integrin  
 Rho activation and Rho-dependent stress fiber formation mediated by GPCRs are 
controlled by heterotrimeric G proteins in the G12/13 family (Buhl et al., 1995; Xu et al., 
2003b). Generally, GPCRs that stimulate stress fiber formation also couple to Gq/11 but 
regulate stress fiber assembly through activation of either G12 or G13 (Gohla et al., 1999).  
Here, we directly investigated whether the RGD integrin-binding domain of the P2Y2R is 
required for activation of specific G proteins (i.e., G12 and Gq).  Results indicated a 2.5 
fold increase in [35S]GTPγS binding to Gα12 immunoprecipitated from UTP-treated 
membrane extracts of 1321N1 cells expressing the wild type P2Y2R as compared to 
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untreated controls, but extracts from cells expressing the RGE mutant receptor did not 
exhibit an increase in [35S]GTPγS binding to Gα12 in response to UTP (Fig. II-5A). In 
contrast, UTP induced a 2-3 fold increase in [35S]GTPγS binding to Gαq upon activation 
of either the wild type or RGE mutant P2Y2R (Fig. II-5B).  Activation of G12/13 and 
Gq/11 proteins by the P2Y2R was also verified by analyzing serine/threonine 
phosphorylation of Gα12/13 (Kozasa and Gilman, 1996) and tyrosine phosphorylation of 
Gαq/11 (Umemori et al., 1997), as previously described. We found that UTP caused 
phosphorylation of both Gα12 and Gαq in 1321N1 cells expressing the wild type P2Y2R 
(Fig. II-5C), whereas no phosphorylation of Gα13 was detected in these cells (data not 
shown). UTP caused phosphorylation of Gαq but not Gα12 in cells expressing the RGE 
mutant P2Y2R (Fig. II-5C), suggesting that αv integrin interaction with the P2Y2R is 
required for UTP-induced activation of G12 but not Gq.  
  To further assess whether αv integrins are involved in P2Y2R-mediated activation 
of Gα12, we tested the effects of inhibition of αV activity or expression using anti-αv 
integrin antibodies or αv antisense oligonucleotides, respectively.  We found that Gα12 
phosphorylation by UTP was inhibited by pretreatment with anti-αv but not with anti-α3 
integrin antibodies in 1321N1 cells expressing the wild type P2Y2R (Fig. II-6A). 
Likewise, transfection of αv antisense oligonucleotides in 1321N1 cells expressing the 
wild type P2Y2R, which significantly suppressed αv expression (Fig. II-6B), completely 
inhibited Gα12 activation by UTP, as assessed by GTPγS binding (Fig. II-6B).  
Transfection of these cells with αv sense oligonucleotides did not inhibit Gα12 activation 
by UTP (Fig. II-6B). Together, these results suggest that αV integrin expression and 
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activity are required for P2Y2R/Gα12 coupling.  
 
P2Y2R accesses Gα12 in a complex with αv integrins  
 To determine whether the P2Y2R interacts with Gα12 in a complex with αV 
integrins, co-immunoprecipitation experiments were performed. Results indicated that 
endogenous αv integrin co-immunoprecipitated with the HA-tagged wild type P2Y2R to a 
much greater extent than with the HA-tagged RGE mutant P2Y2R expressed in 1321N1 
cells (Fig. II-7A).  This association between αv integrin and the wild type P2Y2R 
occurred with or without activation of the P2Y2R, although 5 min stimulation with UTP 
did cause a slight but reproducible reduction in association between these proteins (Fig. 
7A).  We also found that endogenous Gα12 co-immunoprecipitated with the wild type 
P2Y2R but not with the RGE mutant, whereas endogenous Gαq co-immunoprecipitated 
with both P2Y2R constructs (Fig. II-7A).  Co-immunoprecipitation of both Gαq and 
Gα12 with the wild type P2Y2R was inhibited after UTP treatment (Fig. II-7A), consistent 
with the concept that activation of GPCRs causes the release of receptor-coupled G 
protein subunits, thus triggering various downstream responses. Although we were unable 
to detect association between Gα12 and αv integrins when endogenous levels of these 
proteins were used, we did find that wild type Gα12 overexpressed in 1321N1 cells 
co-immunoprecipitated with endogenous αv integrins but not with endogenous α3 
integrins (Fig. II-7B), suggesting that G12 selectively associates with complexes 
containing αv integrins.  Interestingly, UTP treatment did not cause dissociation of Gα12 
and αv integrins (Fig. II-7B) and fluorescence microscopy images indicated that UTP 
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treatment caused a slight redistribution of Gα12 and Gαo onto membrane protrusions or 
lamellipodia in 1321N1 cells (Fig. II-8).      
 
Gα12 activity is required for P2Y2R-mediated stress fiber formation and cell migration  
 To verify that G12 protein is responsible for P2Y2R-mediated Rho activation and 
downstream signaling events, a dominant negative mutant of Gα12 (Gα12DN, 
Q231L/D299N) was used (Yang et al., 2005). Overexpression of Gα12DN in 1321N1 
cells expressing the wild type P2Y2R completely inhibited UTP-induced Rho activation, 
cofilin phosphorylation, stress fiber formation and cell migration (Figs. II-9A, C and D), 
but did not inhibit UTP-induced ERK1/2 phosphorylation (Fig. II-9B), indicating that G12 
is specifically required for P2Y2R-mediated Rho activation and Rho-dependent signaling 
events leading to stress fiber formation and ultimately, cell migration. 
 
Discussion                           
 The G protein-coupled P2Y2R is known to activate several heterotrimeric G 
proteins, including Go and Gq (Erb et al., 2001; Boarder et al., 1995). In this study, we 
show for the first time that the P2Y2R is also able to activate G12 and to initiate 
chemotactic signaling events downstream of G12, including Rho activation, cofilin 
phosphorylation, stress fiber formation and directional cell migration (Figs. II-1, II-5, and 
II-9).  Furthermore, we demonstrate here and in previous studies that an RGD 
integrin-binding domain in the first extracellular loop of the P2Y2R is necessary for the 
P2Y2R to activate Go and G12, but not Gq (Fig. II-5) (Bagchi et al., 2005; Erb et al., 2001), 
suggesting that integrin complexes provide the P2Y2R with access to select pools of 
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heterotrimeric G proteins.  Since the P2Y2R is known to interact with αV integrins (Erb 
et al., 2001), we performed a series of co-immunoprecipitation experiments to verify that 
this interaction is required for the P2Y2R to access G12 protein. These experiments 
showed that 1) Gα12 co-immunoprecipitated with αV integrins but not with α3 integrins; 2) 
the P2Y2R co-immunoprecipitated with Gαq, Gα12 and αv integrins; and 3) mutation of 
the P2Y2R integrin-binding domain (i.e., substitution of RGD with RGE that does not 
bind integrins) did not affect the P2Y2R’s ability to co-immunoprecipitate with Gαq but 
inhibited P2Y2R co-immunoprecipitation with Gα12 and αv integrins (Fig. II-7). Although 
many studies suggest that amino acids located in intracellular loop 2 and the NH2- and 
COOH-terminal portions of intracellular loop 3 are the key elements responsible for 
GPCR selectivity of G protein recognition (Wess, 1997), the results presented here 
suggest that αv integrin complexes are also important for establishing interaction between 
select G proteins and a GPCR.  And, although it is well known that GPCRs require 
integrin activity to stimulate chemotaxis (Miettinen et al., 1998; Till et al., 2002), this is 
the first indication that a GPCR requires interaction with an integrin to provide access to 
specific heterotrimeric G proteins that regulate chemotaxis. 
 Similar to GPCR-mediated chemotaxis, there is some evidence that growth factor 
receptors and integrins use heterotrimeric G proteins to stimulate chemotaxis.  Pertussis 
toxin (PTX), which specifically inactivates Gi/o proteins by covalent modification of the 
α subunits, has been found to inhibit VEGF-induced monocyte migration (Barleon et al., 
1996) as well as growth factor-induced Rac1 and Cdc42 activation by a chimeric 
EGF/VEGF receptor (Zeng et al., 2002).  In addition, the latter study determined that 
overexpression of the Gβγ sequestering minigene, hβARK1, inhibited growth 
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factor-induced Rac1 and Cdc42 activation, suggesting that βγ subunits of PTX-sensitive 
Gi/o proteins are involved in growth factor-induced activation of Rac and Cdc42 (Zeng et 
al., 2002).  Vitronectin-induced chemotaxis of human melanoma cells mediated by the 
αvβ3 integrin is also inhibited by PTX (Aznavoorian et al., 1996), suggesting a role for 
Gi/o proteins in this process.  Although the mechanism of heterotrimeric G protein 
activation by growth factor receptors and integrins is unclear, it is possible that these 
chemoattractant receptors stimulate the release of ATP, thus triggering activation of G 
protein-coupled nucleotide and nucleoside receptors involved in chemotaxis. In support 
of this idea, studies have demonstrated that ATP is released from epithelial cells 
(McNamara et al., 2001; 2006) and migrating neutrophils (Chen et al., 2006) upon 
exposure to chemotactic bacterial proteins. 
 Recently, the general importance of the P2Y2R and the adenosine A3 receptor in 
mediating chemotaxis towards bacterial proteins was demonstrated in neutrophils (Chen 
et al., 2006).  The authors showed that ATP is released at the leading edge of human 
neutrophils migrating towards the bacterial chemoattractant N-formyl-Met-Leu-Phe 
(fMLP) and is rapidly broken down to adenosine by ecto-ATPases on the cell surface.  
In vivo assessment of neutrophil infiltration into the peritoneal cavity of P2Y2R-/- and A3 
receptor-/- mice injected with a murine chemotactic protein 
(Trp-Lys-Tyr-Met-Val-Met-NH2) or with Staphylococcus aureus bacteria indicated that 
both the P2Y2R and the adenosine A3 receptor are required for neutrophil recruitment. 
Furthermore, neutrophils lacking the adenosine A3 receptor migrated toward 
Trp-Lys-Tyr-Met-Val-Met-NH2, but with diminished speed, whereas neutrophils lacking 
the P2Y2R showed a loss in sensing of the chemoattractant gradient.  In agreement with 
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Chen et al.’s findings in neutrophils, we found that the P2Y2R remains evenly distributed 
in the plasma membrane of 1321N1 cells after receptor activation (not shown), which 
supports the conclusion that the P2Y2R controls chemotaxis by sensing and amplifying 
signals induced by chemoattractants.  
 Results presented in this study demonstrate that Gα12 selectively associates with 
complexes containing αv integrins (Fig. II-7). Although the mechanism of this interaction 
is unclear, it is possible that the cadherin family of cell-surface adhesion proteins may be 
involved since Gα12 has been found to interact with the cytoplasmic tails of several 
cadherins (Meigs et al., 2001) and E-cadherin is known to associate with αv integrins 
(von Schlippe et al., 2000).  Another mechanism of αv/Gα12 association may involve 
Tec tyrosine kinases.  Members of the Tec family have been found to interact directly 
with Gα12 and with focal adhesion kinase (Jiang et al., 1998; Chen et al., 2001), thus 
linking G12 to integrin complexes.  Furthermore, Gα12 can interact directly with 
leukemia-associated RhoGEF (LARG) and, upon phosphorylation of LARG by Tec, Gα12 
effectively stimulates the RhoGEF activity of LARG (Suzuki et al., 2003).  Although we 
were unable to detect LARG expression in 1321N1 cells (data not shown), LARG 
belongs to a subfamily of RhoGEFs (including Lsc/p115 RhoGEF and PDZ-RhoGEF) 
that, unlike other RhoGEFs, contains a regulator of G protein signaling (RGS) domain 
that facilitates binding to Gα12/13 (Fukuhara et al., 1999; Fukuhara et al., 2000; Reuther et 
al., 2001; Francis et al., 2006) and, in some instances, Gαq (Booden et al., 2002; Vogt et 
al., 2003).  Members of this RhoGEF subfamily share the ability to specifically activate 
RhoA but not other Rho family GTPases, such as Rac1 and Cdc42 (Banerjee and 
Wedegaertner, 2004).  Therefore, the link between this subfamily of RhoGEFs and the 
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P2Y2R warrants further investigation to better define how P2Y2Rs access G12 in 
αv-containing complexes.  
 In summary, the present study indicates that the P2Y2R requires interaction with 
αv integrins to access G12, but not Gq, and to stimulate chemotactic signaling events 
mediated by G12, including Rho activation, cofilin and MLC-2 phosphorylation and stress 
fiber formation. Since our previous work indicated that the P2Y2R also requires 
interaction with αV integrins to activate Go and Go-mediated cell migration (Bagchi et al., 
2005), these studies establish that αv integrin complexes are required for the P2Y2R to 
access select heterotrimeric G proteins involved in chemotaxis. 
 
Materials and Methods 
Materials 
Anti-human αv (Q20), αvβ5 (P1F76) and α3 (Ralph 3.2) monoclonal Abs, mouse IgG, 
polyclonal rabbit anti-human Gα12, anti-human Gαq/11, and anti-human ERK1/2 
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal 
rabbit anti-human cofilin, anti-phospho-cofilin, anti-phospho-MLC-2, and 
anti-phospho-ERK1/2 antibodies were purchased from Cell Signaling (Beverly, MA). 
The polyclonal rabbit anti-human actin antibodies were purchased from Cytoskeleton 
(Denver, CO). The mouse antiphosphoserine/threonine antibody and the anti-αv integrin 
antibody for immunoblot analysis were purchased from BD Bioscience (San Jose, CA). 
The mouse anti-phosphotyrosine antibody was purchased from Upstate Biotechnology 
(Lake Placid, NY). Anti-HA conjugated agarose beads and anti-HA antibody were 
purchased from Covance (Berkeley, CA). Oregon Green-conjugated phalloidin, 
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rhodamine-conjugated phalloidin and Texas Red-conjugated DNase I were purchased 
from Molecular Probes (Eugene, OR). The Rho-dependent kinase inhibitor Y27632 was 
purchased from Calbiochem (Indianapolis, IN). All other reagents including nucleotides 
were obtained from Sigma-Aldrich (St. Louis, MO), unless otherwise specified. 
 
Cell Culture and Transfection  
Human 1321N1 astrocytoma cells were cultured in Dulbecco's modified Eagle's 
medium (Invitrogen) containing 5% (v/v) fetal bovine serum, 100 units/ml penicillin, and 
100 µg/ml streptomycin and maintained at 37 °C in a humidified atmosphere of 5% C02 
and 95% air.  Cells were stably transfected with cDNA encoding either the wild type or 
RGE mutant P2Y2R, as previously described (Erb et al., 2001).  Both receptor 
constructs contained sequence encoding a hemagglutinin (HA) tag at the amino terminus 
of the P2Y2R, as previously described (Erb et al., 2001). To make the AAA-P2Y2R 
mutant, the RGD sequence was also substituted with Ala-Ala-Ala using the QuikChange 
XL site-directed mutagenesis kit (Stratagene, CA), and the HA-tagged P2Y2R cDNAs 
were excised from pLXSN vectors by digesting with EcoRI and BamHI, and ligated into 
the pcDNA3.1(-) mammalian expression plasmid. The Gα12 wild type and 
dominant-negative construct (Q231L/D299N) were obtained from Guthrie Cdna 
Resource Center (Sayre, PA). Human 1321N1 cells expressing the wild type P2Y2R were 
cultured to 80% confluence and transiently transfected with the Gα12 constructs in the 
pcDNA3.1+ vector using the Lipofectamine 2000 reagent (Invitrogen, CA). The 
transfection efficiency for the Gα12 constructs was determined to be ~60% using an 
indirect immunofluorescence assay.  The day prior to experimental use of the cells, the 
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growth medium was replaced with serum-free medium. The αv integrin was suppressed 
with αv antisense oligonucleotides, as previously described (Bagchi et al., 2005). 
 
Actin Stress Fiber Formation  
Cells were plated on glass coverslips and treated as indicated at 37 °C in serum-free 
DMEM. Then, cells were washed in PBS, fixed for 10 min in 3.7% (v/v) formaldehyde, 
treated with 0.5% (v/v) Triton X-100, and rinsed in PBS.  For staining of F-actin, cells 
were incubated with 5 µg/ml 488 Oregon Green-conjugated phalloidin for 45 min at 
room temperature and then washed with PBS. Texas Red-labeled DNaseI (5 µg/ml) was 
used to localize monomeric G-actin.  In Figure II-8C, cells were incubated with rabbit 
anti-Gα12 antibody, washed and then stained with rhodamine-conjugated phalloidin and 
Oregon Green-labeled goat anti-rabbit IgG for 45 mins. Coverslips were mounted on 
glass slides in ProLong antifade reagent (Molecular Probes) and examined using 
fluorescence microscopy (Nikon, Eclipse TE300) at room temperature. The objective was 
a Nikon Plan Fluor 40X/0.60 lens. Images were acquired and processed with Northern 
Eclipse 6.0 software via a QImaging camera (Qimaging, British Columbia, Canada).  
Single cells were selected by cropping the image. 
 
Rho Activity Assay  
 A Rho activation assay kit (Upstate Biotechnology) was used to assess Rho 
activity according to the manufacturer’s instructions. Briefly, cells were cultured in 100 
mm tissue culture dishes in culture medium and starved with serum-free medium for 24 
hours before stimulated with UTP for 5 min at 37 °C. Cells then were washed three times 
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with ice-cold PBS, suspended in Lysis Buffer containing 125 mM HEPES, pH 7.5, 750 
mM NaCl, 5% (v/v) Igepal CA-630, 50 mM MgCl2, 5 mM EDTA and 10% (v/v) glycerol, 
and the lysates were transferred to 1.5 ml tubes. Forty microliters of Rhotekin Rho 
binding domain (RBD)-agarose that only recognizes GTP-bound Rho were added to 500 
µl of lysate for 45 min at 4 °C. The beads were pelleted by centrifugation (30 sec; 14,000 
x g; 4 °C) and washed three times with Lysis Buffer. Finally, the beads were resuspended 
in 40 ml of 2X Laemmli’s sample buffer (120 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 10% 
(w/v) sucrose, 1 mM EDTA, 50 mM dithiothreitol, and 0.003% (w/v) bromophenol blue) 
and Western blot analysis (see below) was performed with 1:1000 anti-Rho antibody 
(Upstate Biotechnology).  
 
[35S]GTPγS Binding Assay  
Membranes (80 µg of protein) from 1321N1 astrocytoma cell transfectants 
expressing the wild type or RGE mutant P2Y2R or the pLXSN vector were isolated, as 
previously described (Tian et al., 1994), and incubated in assay buffer (50 mM Tris-Cl, 
pH 7.4, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 1 mM DTT, 1 µM guanosine 
5’-diphosphate, 1X protease inhibitor cocktail (Roche), and 50 nCi of [35S]GTPγS; 1250 
Ci/mmol; Perkin Elmer, CA) containing the indicated concentration of UTP. Samples 
were incubated for 20 min at 30 °C followed by addition of 0.5 ml of ice-cold buffer 
containing 50 mM Tris-Cl (pH 7.4), 100 mM NaCl, and 5 mM MgCl2. The samples were 
centrifuged at 100,000 x g for 15 min at 4 °C and the resulting pellets were resuspended 
in 500 µl of solubilization buffer (100 mM Tris, pH 7.4, 200 mM NaCl, 1 mM EDTA, 
1.25% (v/v) NP40, 0.2% (w/v) SDS, and 1X protease inhibitor cocktail). Extracts were 
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incubated overnight with 1:1000 anti-Gα12 or anti-Gαq antibody at 4 °C. The extract was 
then incubated with 50 µl of a 50% (v/v) protein G-agarose suspension, and the immune 
complexes were collected by centrifugation and washed three times in wash buffer (50 
mM Tris-Cl, pH 7.4, 100 mM NaCl, and 5 mM MgCl2). [35S]GTPγS binding in the 
immunoprecipitates was quantified by liquid scintillation counting.  
 
Immunoblot Analysis and Immunoprecipitation  
Immunoblotting (IB) was performed as previously described (Liu et al., 2004).  
After the IB procedure, the membranes were stripped and reprobed with anti-actin or 
anti-ERK1/2 antibody to assess protein loading.  Lysates from 1321N1 cell transfectants 
expressing the HA-tagged wild type or RGE mutant P2Y2R, or the pLXSN vector were 
used for immunoprecipitation (IP) with anti-HA conjugated agarose beads, as previously 
described (Liu et al., 2004).  IP was also performed with cell lysates and anti-αvβ5 or 
anti-α3 antibody or normal goat IgG (negative control). The immune complexes were 
precipitated by protein G-conjugated beads and analyzed by IB with anti-G12 antibody. 
Phosphorylation of G proteins was detected by IP of G12 or tyrosine-phosphorylated 
proteins using anti-G12 or anti-phosphotyrosine antibody, respectively. The 
immunoprecipitated samples were analyzed by IB with anti-phosphoserine/threonine or 
anti-Gq antibody, respectively.  
 
Cell Migration Assay 
Cell migration assays were performed with 8-µm pore size Transwells (Costar), as 
described (Bagchi et al., 2005). In brief, the cells were cultured at 37 °C for 24 h in 
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DMEM supplemented with 5% (v/v) fetal bovine serum, suspended by trypsinization, 
washed, and resuspended in 100 µl of serum-free DMEM (5 × 104 cells) and placed in the 
upper chamber of the Transwells. The lower chamber was filled with 600 µl of 
serum-free medium with or without 100 µM UTP. The cells were allowed to migrate for 
16 h at 37 °C. Cells migrating to the lower side of the membrane were fixed with cold 
methanol and stained with Accustain. Cells were counted in 10 microscopic fields at 20X 
magnification. 
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Figure II-1. P2Y2R-mediated Rho activation and stress fiber formation require 
P2Y2R interaction with αv integrins. (A) Cell surface expression of HA-tagged wild 
type (WT) or RGE mutant (RGE) P2Y2Rs in 1321N1 cells was determined by flow 
cytometry. Cells stained with only secondary antibody were used as a negative control. 
(B) Cells expressing the WT or RGE mutant P2Y2R were treated with or without 1 mM 
UTP for 5 min prior to measuring ERK1/2 phosphorylation and Rho activity.  Results 
shown are representative of 3 experiments. (C) Cells expressing the WT or RGE mutant 
P2Y2R were treated with or without 1 mM UTP or 20% FBS (positive control) for the 
indicated time and stress fibers were visualized by staining filamentous actin (shown in 
green) with Oregon-Green labeled phalloidin. Texas Red-labeled DNase I was used to 
label monomeric actin (shown in red). More than 100 cells were examined in three 
separate experiments, and representative images are shown. Bar = 50 µm.  
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Figure II-2. ERK1/2 and Rho activation mediated by WT and AAA mutant P2Y2Rs.  
Human 1321N1 cells were transiently transfected with either WT (RGD) or AAA mutant 
P2Y2R cDNA in pcDNA3.1(-).  Transfected cells were starved overnight and stimulated 
with the indicated concentration of UTP for 5 min prior to measuring ERK1/2 
phosphorylation (A) or Rho activity (B).  (A) UTP-induced phosphorylation of ERK1/2 
was expressed as fold increase over basal levels. Data points represent the means ± 
S.E.M. of results from three experiments. (B) The Rho-GTP band density was normalized 
to total Rho and relative intensities are shown below each band as means ± S.E.M. of 
results from four experiments. 
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Figure II-3. P2Y2R-mediated Rho activation and stress fiber formation require αv 
integrin activity. Human 1321N1 cells expressing the WT P2Y2R were incubated 
overnight at 37 °C in serum-free medium with 10 µg/ml anti-αvβ5 or anti-α3 antibody. 
Cells were then treated with or without 100 µM UTP for 5 min prior to analysis of Rho 
activity (A) or 30 min prior to analysis of stress fiber formation (B).  (A) Representative 
blots from three experiments are shown.  (B) More than 100 cells were examined in 
three separate experiments, and representative images are shown. Bar = 50 µm.  
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Figure II-4.  P2Y2R/αv integrin interaction regulates Rho-mediated signaling. (A 
and B) Human 1321N1 cells expressing the WT or RGE mutant P2Y2R were incubated 
with the indicated concentration of UTP for 5 min at 37 °C. Cell lysates were prepared 
and analyzed by immunoblotting with (A) anti-phospho-myosin light chain 2 (p-MLC-2) 
or (B) anti-phospho-cofilin antibodies. (C) Cells expressing the WT P2Y2R were 
incubated overnight with or without 10 µg/ml anti-αvβ5 or anti-α3 antibody, then 
stimulated with 100 µM UTP for 5 min at 37 °C. Cell lysates were prepared and analyzed 
by immunoblotting with anti-phospho-cofilin antibodies. Relative intensities are shown 
below each band as means ± S.E.M. of results from three experiments. (D) Cells 
expressing the WT P2Y2R were pretreated at 37 °C in serum-free medium with the 
Rho-dependent kinase inhibitor Y-27632 (10 µM) for 1 h or 200 ng/ml Bordetella 
pertussis toxin (PTX) overnight, then stimulated with 100 µM UTP for 5 min at 37 °C. 
Cell lysates were analyzed by immunoblotting with anti-phospho-cofilin antibodies.  
Protein loading in each lane was evaluated by stripping the membrane of antibodies and 
re-probing with anti-actin antibodies.  Blots representative of three-five experiments are 
shown. 
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Figure II-5. P2Y2R/αv integrin interaction is required for G12 coupling.  (A and B) 
Membrane preparations from 1321N1 cells expressing the WT or RGE mutant P2Y2R or 
pLXSN vector-transfected cells (negative control) were used in [35S]GTPγS binding 
assays in the presence or absence of 1 mM UTP (see “Materials and Methods”). After 
termination of the assay, samples were immunoprecipitated with antiserum against (A) 
Gα12 or (B) Gαq/11 and radioactivity in the immunoprecipitates was calculated. Data are 
the means ± S.E.M. of results from three separate experiments and are shown as fold 
increase over untreated cells.  (C) Human 1321N1 cells expressing the WT or RGE 
mutant P2Y2R were incubated with 1 mM UTP for 2 min at 37 °C. G12 activation was 
detected by immunoprecipitation (IP) of Gα12 with anti-Gα12 antibody and 
immunoblotting (IB) of Gα12 with anti-phosphoserine/threonine antibody.  Gq/11 
activation was detected by IP with anti-phosphotyrosine antibody and IB with anti-Gαq/11 
antibody.  Blots representative of three experiments are shown.  
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Figure II-6. P2Y2R-mediated G12 activation requires αv integrin expression and 
activity. (A) Cells expressing the WT P2Y2R were incubated overnight at 37 °C in 
serum-free medium with 10 µg/ml anti-αvβ5 or anti-α3 antibody, then stimulated with 100 
µM UTP for 2 min at 37 °C.  Gα12 phosphorylation was detected, as described in Fig. 5.  
Relative intensities are shown below each band as means ± S.E.M. of results from four 
experiments. (B) Cells expressing the WT P2Y2R were transfected with 5 µg of αv 
antisense (AS) or sense (S) oligonucleotides, as described (Bagchi et al., 2005). 
Lipofectamine transfected cells served as a negative control.  Expression of αv integrin 
in these cells was determined by immunoblot analysis and a representative blot is shown.  
UTP-induced binding of [35S]GTPγS to Gα12 was determined, as described in Fig. 5.  
Data are the means ± S.E.M. of results from three separate experiments and are shown as 
fold increase over untreated cells.   
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Figure II-7. The P2Y2R accesses G12  in a complex with αv integrins. (A) 
RGD-dependent association of the P2Y2R with αv integrins and Gα12. Cells expressing 
the HA-tagged WT or RGE mutant P2Y2R and endogenous Gq/11, G12 and αv integrins 
were treated with or without 1 mM UTP for 5 min at 37 °C and lysates were subjected to 
IP with mouse anti-HA antibody conjugated to agarose beads and IB with anti-Gα12, 
anti-Gαq/11, anti-αv integrin, or anti-HA antibody.  Cells transfected with the pLXSN 
vector served as a negative control. (B) Gα12 associates with αv integrins.  Human 
1321N1 cells expressing cDNAs for the WT P2Y2R and Gα12 were treated with or 
without 100 µM UTP for 5 min at 37 °C and lysates were subjected to IP with IgG, 
anti-α3 integrin, or anti-αv integrin antibody followed by IB with anti-Gα12, anti-α3 
integrin or anti-αv integrin antibody. Blots representative of three experiments are shown.   
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Figure II-8. Co-immunostaining of Gα12 and Gαo in cells exposed to a UTP gradient. 
Human 1321N1 cells expressing wild type P2Y2Rs were plated on chambered coverslides 
and incubated overnight in 300 µl serum-free medium at 37 °C in a humidified 
atmosphere of 5% CO2 and 95% air.  UTP (1 µl of a 100 mM solution) was added at the 
bottom left and after 30 min at 37 °C, cells were washed, fixed, permeabilized and 
stained with rabbit anti-Gα12  and mouse anti-Gαo antibodies. Texas Red-conjugated 
anti-rabbit IgG and Alexa Fluor 488 conjugated anti-mouse IgG were then used to 
localize Gα12 and Gαo, respectively. The slides were examined by fluorescence 
microscopy, as described in “Materials and Methods”, and images representative of three 
experiments are shown. Arrows indicate membrane protrusions indicative of lamellipodia 
formation. 
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Figure II-9. Effect of dominant-negative Gα12 (Gα12 DN) on signaling events 
mediated by the P2Y2R. (A-D) Human 1321N1 cells expressing the WT P2Y2R were 
cultured to 80% confluence and transiently transfected with the Gα12DN mutant in the 
pcDNA3.1+ vector. MOCK: vector transfected negative control.  Transfected cells were 
incubated with 100 µM UTP for 5 min (A and B) or 30 min (C) at 37 °C and assayed for 
(A) Rho activity and cofilin phosphorylation, (B) ERK1/2 phosphorylation and (C) stress 
fiber formation, as described in “Materials and Methods”.  Total Gα12 was detected with 
anti-Gα12 antibody, as shown in (A).  Antibody-labeled Gα12 in (C) is shown in red and 
phalloidin-labeled filamentous actin is shown in green.  (D) Cells (5 × 104) transfected 
with the indicated constructs were seeded into the upper chamber of Transwells. Lower 
chambers contained serum-free medium with or without 100 µM UTP.  Cell migration 
was evaluated 16 h after UTP stimulation at 37 °C and expressed as the fold increase in 
the number of cells that moved across the Transwell membranes in response to UTP as 
compared to untreated controls.  (A and B) Blots representative of three-five 
experiments are shown.  (C) Images representative of three separate experiments are 
shown.  Bar = 40 µm. (D) Data shown are the means ± S.E.M. of results from five 
experiments. 
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Supplemental Figure II-S1.  UTP induces a dose-dependent activation of Rho in 
1321N1 cells expressing P2Y2 receptors.  Human 1321N1 cells expressing the WT 
P2Y2R were treated with the indicated concentration of UTP for 5 min at 37 °C. Rho 
activity was then measured, as described in "Materials and Methods". UTP-induced Rho 
activation is expressed as a percentage of maximum response levels. Data points 
represent the means ± S.E.M. of results from three experiments. 
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Supplemental Figure II-S2.  Effects of  anti-αvβ5 integrin antibody on UTP- and 
FBS-stimulated Rho activation.  Human 1321N1 cells expressing the WT P2Y2R were 
incubated overnight at 37 °C in serum-free medium with 10 µg/ml of anti-IgG or 
anti-αvβ5 antibody. Cells were then treated with or without 100 µM UTP or 10% (v/v) 
fetal bovine serum (FBS) for 5 min at 37 °C prior to analysis of Rho activity. 
Representative blots and relative intensities as means ± S.E.M. of results from three 
experiments are shown. 
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CHAPTER III 
The P2Y2 nucleotide receptor interacts with αv integrins to activate Go 
and induce cell migration 
 
Abstract 
Extracellular ATP and UTP induce chemotaxis, or directed cell migration, by 
stimulating the G protein-coupled P2Y  nucleotide receptor (P2Y R).  Previously, we 
found that an arginine-glycine-aspartic acid (RGD) integrin-binding domain in the P2Y R 
enables this receptor to interact selectively with α β  and α β  integrins, an interaction 
that is prevented by mutation of the RGD sequence to arginine-glycine-glutamic acid 
(RGE) (Erb et al., 2001). This RGD domain also was found to be necessary for coupling 
the P2Y R to G - but not G -mediated intracellular calcium mobilization, leading us to 
investigate the role of P2Y R interaction with integrins in nucleotide-induced chemotaxis.  
Here we show that mutation of the RGD sequence to RGE in the human P2Y R 
expressed in 1321N1 astrocytoma cells completely prevented UTP-induced chemotaxis 
as well as activation of G , Rac, and vav2, a guanine nucleotide exchange factor for Rac.   
P2Y R-mediated chemotaxis, Rac and vav2 activation were inhibited by pretreatment of 
the cells with anti-α β  integrin antibodies or the G  inhibitor, pertussis toxin.  Thus, 
the RGD-dependent interaction between the P2Y R and α  integrins is necessary for the 
P2Y R to activate G  and to initiate G -mediated signaling events leading to chemotaxis. 
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Chemotaxis is the movement of a cell in response to a chemical gradient and is 
required for many physiological events, including embryonic development, immune 
system function, and wound healing (Cox and Huttenlocher, 1998; Sanchez-Madrid and 
del Pozo, 1999; Van Haastert and Devreotes, 2004). The process of chemotaxis is also 
important for understanding diseases that result from abnormal cell migration, such as 
chronic inflammation, atherosclerosis, and cancer metastasis. To migrate, cells must 
establish dynamic and highly regulated adhesive interactions with the extracellular matrix, 
which are mediated by integrin receptors (Cox and Huttenlocher, 1998). For example, 
recent studies have shown that αv integrins play an important role in controlling cell 
adhesion, spreading, and motility in several cell types, including human vascular smooth 
muscle cells and pancreatic beta cells (Kaido et al., 2004; Stawowy et al., 2004). Upon 
activation, many types of integrin receptors cluster together and recruit a host of 
cytoskeletal and cytoplasmic proteins into specialized adhesive structures called focal 
adhesions. These focal adhesion complexes not only serve as a physical link between the 
extracellular and intracellular matrix but also are important sites of signal transduction for 
integrins and many other types of receptors that mediate cell migration (Martin et al., 
2002). Chemotaxis also requires a cell to assume a polarized morphology that is 
controlled by cell surface receptors that activate the Rho family of GTPases, including 
Cdc42, Rac, and Rho (Etienne-Manneville and Hall, 2002; Burridge and Wennerberg, 
2004). Upon activation of a chemoattractant receptor, Cdc42 and Rac localize at the 
leading edge of a cell and control directional movement and the formation of 
lamellipodia containing highly branched actin filaments, respectively (Burridge and 
Wennerberg, 2004). Rho localizes at the rear and sides of a cell and controls the 
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formation of contractile actin-myosin stress fibers (Xu et al., 2003b). Together, these 
GTPases promote cell migration towards a chemoattractant by mediating extension of the 
actin cytoskeleton at the front edge of the cell and retraction of the cytoskeleton at the 
rear edge of the cell. 
Recent studies have shown that G protein-coupled receptors (GPCRs) regulate Rac 
and Rac-dependent lamellipodia formation by activating the Gi/o family of heterotrimeric 
G proteins, whereas activation of Rho and Rho-dependent stress fiber formation are 
controlled by the G12/13 family (Xu et al., 2003b). Furthermore, studies have shown that 
the βγ subunits of Gi/o are responsible for activation of Rac guanine nucleotide exchange 
factors (RacGEFs) that, in turn, activate Rac, whereas the α subunits of G12/13 are 
responsible for activation of RhoGEFs (Neptune and Bourne, 1997; Burridge and 
Wennerberg, 2004). 
The P2Y2 nucleotide receptor (P2Y2R), a GPCR activated by extracellular ATP or 
UTP, is an important regulator of monocyte chemotaxis (Seye et al., 2002). Although the 
P2Y2R is normally expressed in monocytes, neutrophils, and other immune cells (Jin et 
al., 1998), recent studies have shown that the P2Y2R is up-regulated in epithelial and 
vascular tissue in response to injury or stress (Seye et al., 1997). Upon activation, the 
P2Y2R mediates a variety of biological functions, including mitogenesis, angiogenesis, 
vasodilation, chemotaxis, and inflammation (Satterwhite et al., 1999; Chaulet et al., 
2001).  Furthermore, recent work from our group has demonstrated that arterial stress in 
rabbit carotid arteries induces up-regulation of the P2Y2R in vascular endothelium and 
smooth muscle and that in vivo activation of the P2Y2R by UTP leads to a 7-fold increase 
in intimal thickening and a 4-fold increase in leukocyte infiltration into the neointima 
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(Seye et al., 2002). Thus, the P2Y2R represents an exciting target for wound healing as 
well as chronic inflammatory diseases.  
Previously, we reported that the P2Y2R contains a consensus RGD integrin-binding 
domain in the first extracellular loop that interacts with αvβ3 and αvβ5 integrins (Erb et al., 
2001). Furthermore, we found that the RGD domain in the P2Y2R is required for Go- but 
not Gq-mediated calcium signaling (Erb et al., 2001), leading us to speculate that αv 
integrin interaction with the P2Y2R is important for nucleotide-induced chemotaxis. The 
purpose of the present study was to evaluate the role of αv integrin interaction with the 
P2Y2R in nucleotide-induced chemotaxis and to identify upstream signaling events 
involved in P2Y2R-mediated chemotaxis. 
 
Results 
An RGD integrin-binding domain in the P2Y2R is required for UTP-induced cell 
migration  
We previously reported that interaction between the P2Y2R and αv integrins is 
prevented by mutation of the P2Y2R RGD sequence to RGE (Erb et al., 2001). To 
determine whether the RGD integrin-binding domain in the P2Y2R is important for 
P2Y2R-mediated chemotaxis, a modified Boyden chamber assay was used.  The results 
showed that UTP induced a concentration-dependent increase in the migration of cells 
transfected with the WT P2Y2R in contrast to cells transfected with the RGE mutant 
P2Y2R or vector alone (Fig. III-1). Also, we found that P2Y2R-transfected cells did not 
migrate significantly when UTP was placed in the upper chamber instead of the lower 
chamber or when equal concentrations of UTP were placed in both chambers (data not 
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shown), indicating that UTP acts as a chemoattractant in cells expressing the WT P2Y2R. 
The cell transfectants expressed similar surface levels of WT and RGE mutant P2Y2Rs 
and αv integrin, suggesting that variations in the magnitude of UTP-induced migration 
were not due to differences in cell-surface protein levels (Bagchi et al., 2005).  Thus, the 
RGD integrin-binding domain of the P2Y2R is apparently required for UTP-induced 
chemotaxis. 
 
The P2Y2R RGD domain is required for UTP-induced activation of vav2 and Rac  
The Rac subfamily of small GTPases stimulates the formation of lamellipodia and is 
necessary for cell migration (Allen et al., 1997; Hall, 1998). Furthermore, the efficiency 
of Rac signaling is dependent on RacGEFs, such as vav2 (Das et al., 2000), an 
ubiquitously expressed member of the vav family of RhoGEFs that is necessary for 
lamellipodia formation and activation of Cdc42, Rac1 and RhoA (Schuebel et al., 1998; 
Abe et al., 2000; Liu and Burridge, 2000; Marignani and Carpenter, 2001). Taking into 
consideration the importance of Rac and vav2 in cell motility, we determined whether 
Rac and vav2 are activated by UTP and the relationship of these activities to 
RGD-dependent P2Y2R interaction with αv integrins. We found that even at very high 
UTP concentrations (e.g., 1 mM), vav2 and Rac were only activated in cells expressing 
the WT P2Y2R but not in cells expressing the RGE mutant P2Y2R (Fig. III-2), suggesting 
that the P2Y2R requires interaction with αv integrins to activate Rac and vav2.  
Furthermore, transient transfection of 1321N1 cells expressing the WT P2Y2R with a 
dominant negative mutant of vav2 (vav2 DN) abolished UTP-induced Rac1 activation 
(Bagchi et al., 2005), consistent with the role of vav2-dependent Rac1 activation in 
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lamellipodia formation and cell spreading in other cell lines (Marignani and Carpenter, 
2001). 
 
Functional activity of αv integrins is essential for UTP-induced cell migration, vav2 and 
Rac activation  
To further evaluate the role of αv integrins in P2Y2R-mediated cell migration, we 
tested the effect of anti-integrin Abs on UTP-induced migration and upstream signaling 
events in 1321N1 cells transfected with the WT P2Y2R. The increase in migration of 
P2Y2R-transfected cells in response to UTP was inhibited by anti-αv and anti-αvβ5 Abs in a 
dose-dependent manner, whereas negative control Ab (anti-IgG) did not inhibit 
UTP-induced cell migration (Bagchi et al., 2005). UTP-induced chemokinesis of 
P2Y2R-transfected cells was also inhibited by anti-αvβ5 Ab at a concentration of 50 µg/ml 
(Bagchi et al., 2005), indicating that αv integrins are required for UTP-induced cell 
migration. Likewise, Rac and vav2 activation in response to UTP were significantly 
inhibited by treatment with anti-αvβ5 Ab, but not with Ab against another integrin subtype 
(α3) that is also expressed in 1321N1 cells (Fig. III-3). Note: fluorescence-activated cell 
sorter analysis indicated that αvβ5 and α3 integrins, but not αvβ3, are expressed in 1321N1 
cells (data not shown). 
 
Involvement of Go signaling in P2Y2R-mediated cell migration  
Pertussis toxin (PTX), which inhibits Gi/o signaling, has been shown to block 
chemotaxis mediated by chemokine receptors (Haque et al., 2004). Previous work from our 
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laboratory has shown that PTX partially inhibits intracellular Ca2+ mobilization mediated 
by the WT P2Y2R, but does not block Ca2+ mobilization mediated by the RGE mutant 
P2Y2R, suggesting that the RGD integrin-binding domain is required for the P2Y2R to 
activate Go (Erb et al., 2001). Here, we directly investigated whether the RGD domain in 
the P2Y2R is required for activation of Go.  Accordingly, membrane extracts were 
prepared from 1321N1 cells expressing the WT or RGE mutant P2Y2R and stimulated with 
1 mM UTP in the presence of [35S]GTPγS. Immunoprecipitation of Gαo or Gαq with 
anti-Gαo or anti-Gαq/11 Abs indicated that UTP induced a 2-fold increase in [35S]GTPγS 
binding to Gαo in cells expressing the WT P2Y2R, whereas no increase in [35S]GTPγS 
binding to Gαo was seen in cells expressing the RGE mutant receptor (Bagchi et al., 2005). 
In contrast, activation of both the WT and RGE mutant P2Y2R by UTP induced a 2-fold 
increase in [35S]GTPγS binding to Gαq (Bagchi et al., 2005).  These results directly show 
that the RGD integrin-binding domain in the P2Y2R is required for activation of Go, but not 
Gq, and suggest that integrin interaction with the P2Y2R is important for access to specific 
heterotrimeric G proteins involved in cell migration. 
Furthermore, we found that PTX inhibited UTP-induced cell migration by 70-80% in 
1321N1 cells expressing the WT P2Y2R (Bagchi et al., 2005), indicating that Go activation 
is involved in P2Y2R-mediated cell migration.  PTX also completely inhibited 
UTP-induced vav2 and Rac activation (Fig. III-4) and vitronectin up-regulation (Bagchi et 
al., 2005) in 1321N1 cells expressing the WT P2Y2R, indicating that all of these responses 
are dependent on Go activity.   
 
P2Y2R-mediated Akt phosphorylation does not require integrin interaction  
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The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is known to regulate actin 
reorganization and cell migration by some, but not all, chemokine receptors (Firtel and 
Chung, 2000; Cronshaw et al., 2004), and a recent study has shown that extracellular ATP 
and UTP can increase migration of human umbilical vein endothelial cells (HUVEC) in a 
PI3K-dependent manner (Kaczmarek et al., 2005). Therefore, we investigated whether the 
PI3K/Akt pathway is involved in chemotaxis mediated by the P2Y2R expressed in 1321N1 
cells.  We found that the PI3K inhibitor LY294002 inhibited Akt phosphorylation induced 
by UTP but failed to significantly inhibit UTP-induced migration of 1321N1 cells 
expressing the WT P2Y2R (data not shown). We also found that both the WT and RGE 
mutant P2Y2R could activate Akt but the RGE mutant P2Y2R required ~1000-fold higher 
concentrations of UTP, as compared with the WT P2Y2R (Fig. III-5), which is similar to 
the agonist potency of the RGE mutant P2Y2R in the stimulation of intracellular Ca2+ 
mobilization, ERK1/2 phosphorylation (Erb et al., 2001) and inositol phosphate 
accumulation (Qi et al., 2005). Thus, at high UTP concentrations, both the WT and the 
RGE mutant P2Y2Rs are equally efficacious in the activation of Akt, ERK1/2, intracellular 
Ca2+ mobilization, and inositol phosphate formation.  And, although untested, it was 
recently suggested that the RGE mutation in the P2Y2R may be affecting these pathways 
by decreasing the agonist binding affinity of the P2Y2R (Qi et al., 2005). We next used 
PTX to evaluate the role of Go in P2Y2R-mediated Akt phosphorylation. PTX caused a 
50% inhibition of Akt phosphorylation induced by UTP in 1321N1 cells expressing the 
WT P2Y2R, whereas Akt phosphorylation was insensitive to PTX treatment in cells 
expressing the RGE mutant receptor (Bagchi et al., 2005). Therefore, we conclude that 
P2Y2R-mediated Akt phosphorylation in 1321N1 cells occurs by both Go- and 
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Gq-dependent pathways, although UTP-induced cell migration is largely Go-dependent.  
Moreover, the involvement of the PI3K/Akt pathway in P2Y2R-mediated migration 
appears to be cell type specific and does not play a significant role in P2Y2R-mediated 
chemotaxis in 1321N1 cells.    
 
Discussion 
Previously, we found that an integrin-binding sequence (RGD) in the G 
protein-coupled P2Y2R, promotes interaction with αvβ3/β5 integrins and is required for 
nucleotide-induced activation of Go- but not Gq-mediated intracellular calcium 
mobilization (Erb et al., 2001). In the present study, we have shown that the P2Y2R agonist 
UTP can induce migration of human 1321N1 cells expressing the WT P2Y2R but not a 
P2Y2R in which the RGD sequence was mutated to RGE (Fig. III-1), a sequence change 
that prevents integrin interaction (Erb et al., 2001). Our results strongly suggest that 
interaction of the P2Y2R with αv integrins is essential for UTP-induced cell migration and 
this report is the first demonstration that a GPCR can interact with an integrin to facilitate 
cell migration. In addition, two other lines of evidence demonstrate the involvement of αv 
integrins in P2Y2R-mediated cell migration. First, selective inhibition of αv integrin 
expression by antisense oligonucleotide inhibited UTP-induced cell migration of 1321N1 
cells expressing the WT P2Y2R (Bagchi et al., 2005).  Second, anti-αv and anti-αvβ5 Abs 
inhibited UTP-induced migration of WT P2Y2R transfected cells (Bagchi et al., 2005). 
These observations are consistent with other reports indicating that integrin activity is 
required for both GPCR-mediated (Chernyavsky et al., 2004; Idzko et al., 2004) and 
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growth factor receptor-mediated cell migration (Meyer et al., 2004; Clemmons and Maile, 
2005). 
During cell migration, integrins attach to and detach from their extracellular matrix 
ligands to provide the necessary traction for cell crawling (Zhelev and Alteraifi, 2002). It 
also has been demonstrated that in migrating neutrophils, the active form of the αvβ3 
integrin is concentrated at the leading edge of the cell (Lawson and Maxfield, 1995; 
Kindzelskii et al., 1996; Sanchez-Madrid and del Pozo, 1999) and that this integrin cycles 
between an active (i.e., extracellular matrix-bound form that is tyrosine phosphorylated on 
the β3 subunit) and an inactive conformation in a calcium- and calcineurin-dependent 
manner (Lawson and Maxfield, 1995). In the chemotaxis assays performed in our study, 
the Transwell membranes were not coated with extracellular matrix proteins, and thus we 
presumed that activation of the P2Y2R induced the synthesis and secretion of extracellular 
matrix proteins needed to facilitate cell migration. We demonstrated that UTP increased 
the expression of the extracellular matrix proteins vitronectin and osteopontin (Bagchi et 
al., 2005) in 1321N1 cells expressing the WT but not the RGE mutant P2Y2R, suggesting 
that integrin interaction also is required for up-regulation of extracellular matrix proteins 
by the P2Y2R. Furthermore, anti-vitronectin Abs inhibited UTP-induced migration of 
1321N1 cells expressing the WT receptor (Bagchi et al., 2005). From these observations, it 
seems likely that P2Y2R-mediated cell migration is enhanced by the synthesis and 
secretion of extracellular matrix ligands for αvβ3/β5 integrins. Many extracellular matrix 
proteins like osteopontin and vitronectin contain RGD domains that interact with αvβ3/β5 
integrins (Chaulet et al., 2001). Therefore, it also seems likely that the P2Y2R and 
extracellular matrix proteins compete for binding to αvβ3/β5 integrins and this competition 
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may facilitate the cyclic attachment/detachment of the cell to the extracellular matrix that is 
necessary for cell migration. In support of this idea, we observed that 1321N1 cells 
expressing the WT P2Y2R adhered to vitronectin-coated dishes at a slower rate than 
untransfected cells or cells expressing the RGE mutant (data not shown).  Further 
investigation, however, is required to examine this hypothesis.  
Recent advances in the understanding of the mechanism of F-actin polymerization 
have shown that small GTPases like Cdc42, RhoA, and Rac are major regulators of actin 
dynamics (Hall, 1998; Nobes and Hall, 1999) and play a critical role in cell motility. For 
example, activated Cdc42 stimulates the formation of actin rich filopodia, activated RhoA 
induces the formation of stress fibers and focal adhesions, and activated Rac stimulates the 
formation of lamellipodia and membrane ruffles (Hall, 1998). Rac is also required to 
recruit the active form of αvβ3 integrin to the lamellipodia, which promotes cell migration 
(Kiosses et al., 2001). In our experiments, UTP stimulated Rac activation in 1321N1 cells 
expressing the WT P2Y2R, but not in cells expressing the RGE mutant P2Y2R (Fig. III-2).  
Dominant-negative Rac inhibited UTP-induced migration of cells expressing the WT 
P2Y2R (Bagchi et al., 2005), providing direct evidence for the involvement of Rac in 
P2Y2R-mediated cell migration. The small GTPases cycle between active GTP-bound and 
inactive GDP-bound states depending on their regulation by guanine nucleotide exchange 
factors (GEFs). One GEF for Rac is vav2, which is activated by tyrosine kinase-dependent 
phosphorylation (Bustelo, 2000), and UTP has been found to cause a strong 
time-dependent increase in the tyrosine phosphorylation of vav2 in human coronary artery 
endothelial cells (Liu et al., 2004). In the present study, vav2 phosphorylation was 
stimulated by UTP in 1321N1 cells expressing the WT P2Y2R, but not in cells expressing 
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the RGE mutant P2Y2R (Fig. III-2), suggesting that vav2 phosphorylation, like Rac 
activation, was dependent on P2Y2R interaction with αv integrins. Furthermore, vav2 DN 
completely inhibited UTP-induced Rac activation (Bagchi et al., 2005), thus establishing 
that vav2 plays a crucial role in P2Y2R-mediated Rac activation and chemotaxis. The 
requirement for P2Y2R and αv integrin interaction in the activation of vav2 and Rac was 
demonstrated in two other ways. First, selective inhibition of αv integrin expression with 
αv antisense oligonucleotide inhibited the UTP-induced activation of vav2 and Rac 
(Bagchi et al., 2005). Second, UTP-induced phosphorylation of vav2 and Rac were 
significantly inhibited by an overnight treatment of WT P2Y2R transfected cells with 
anti-αvβ5 Ab (Fig. III-3).  Thus, our results strongly suggest that vav2 and Rac activation 
are required for UTP-induced cell migration, responses that are dependent upon interaction 
between the P2Y2R and αv integrins.  
Heterotrimeric G proteins in the Gi/o family were recently reported to be responsible 
for GPCR-mediated cell migration by activating RacGEFs, which, in turn, activate Rac 
(Burridge and Wennerberg, 2004). In this study, we utilized the [35S]GTPγS binding assay 
to provide direct evidence that the RGD integrin-binding domain in the P2Y2R is required 
for this receptor to activate Go but not Gq (Bagchi et al., 2005). We also found that the Gi/o 
inhibitor PTX decreased UTP-induced migration of 1321N1 cells expressing the WT 
P2Y2R by 70-80% (Bagchi et al., 2005) and completely inhibited P2Y2R-mediated vav2 
and Rac activation  (Fig. III-4). Taken together, these results suggest that αv integrin 
interaction with the P2Y2R is required to activate Go and initiate Go-mediated vav2 and 
Rac activation and vitronectin up-regulation, leading to increased cell migration.   
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These results provide novel insight into the mechanism of chemotactic signaling by a 
GPCR and suggest that αv integrin-based complexes can be important for allowing access 
to specific heterotrimeric G proteins involved in cell migration. Since αv integrins have 
been shown to play a critical role in cell migration and angiogenesis in vascular endothelial 
cells (Kiosses et al., 2001; Ziche et al., 2004), therapeutic strategies that disrupt P2Y2R 
interaction with αv integrins could be useful in the treatment of diseases involving 
inflammation and angiogenesis, such as atherosclerosis, diabetes, Alzheimer’s disease, and 
cancer. 
 
Materials and Methods 
Cell Culture and Transfection   
Human 1321N1 astrocytoma cells were stably transfected with cDNA encoding a 
hemagglutinin (HA)-tagged wild-type (WT) or RGE mutant P2Y2R using the pLXSN 
retroviral vector, as previously described (Erb et al., 1995). The cells were cultured in 
DMEM containing 5% (v/v) fetal bovine serum, 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 500 µg/ml Geneticin (G418, GIBCO BRL) at 37 °C in a humidified 
atmosphere of 5% CO2 and 95% air. Cell surface expression of the HA-tagged WT or 
RGE mutant P2Y2R was determined by flow cytometry, as previously described (Garrad 
et al., 1998). Surface expression of endogenous αv integrin in 1321N1 cells expressing 
the WT or RGE mutant P2Y2R was quantitated by flow cytometry, using a 1:100 dilution 
of mouse monoclonal anti-human αv antibody (P2W7, Santa Cruz Biotechnology) as the 
primary antibody and a 1:100 dilution of goat anti-mouse IgG-FITC (Santa Cruz 
Biotechnology) as the secondary antibody. Cells were washed with PBS, fixed and 
84 
 
analyzed on an EPICS 753 flow cytometer (Coulter Corp., Hialeah, FL). 
 
Migration Assay  
Cell migration assays were performed with 3 µm pore size Transwells (Costar), as 
described (Chaulet et al., 2001). In brief, cells were suspended by trypsinization, washed, 
and resuspended in 100 µl of serum-free DMEM (5x104 cells) and placed in the upper 
chamber of the Transwells. The lower chamber was filled with 500 µl of serum-free 
DMEM supplemented with varying concentrations of UTP (Amersham), as indicated. 
The cells were allowed to migrate for 16 h at 37 °C. Cells migrating to the lower side of 
the polycarbonate membrane were fixed with ice-cold methanol and stained with 
Accustain (Sigma). Cells were counted in 10 microscopic fields at 20X magnification. 
 
Immunoblot Analysis  
Immunoblot analysis was done as previously described (Erb et al., 2001). For signal 
normalization, membranes were probed with a 1:1000 dilution of goat anti-human actin Ab 
(Cytoskeleton Inc.). 
 
Rac activity and vav2 Phosphorylation  
Human 1321N1 cells transfected with the WT or RGE mutant P2Y2R were plated on 
uncoated 100 mm tissue culture dishes, serum-starved for 24 h and stimulated with UTP 
for 5 min at 37 °C. Rac-GTP was precipitated from cell extracts with Rac/Cdc42 Assay 
Reagent (PAK-1 PBD-agarose), comprised of the P-21 binding domain of human PAK-1 
bound to glutathione agarose (Upstate Biotechnology), following the manufacturer’s 
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instructions. SDS-PAGE was performed with the precipitated protein. Rac activity was 
detected by immunoblotting with a 1:1000 dilution of mouse anti-human Rac (clone 
23A8, Upstate Biotechnology) as the primary Ab and a 1:2000 dilution of 
HRP-conjugated goat anti-mouse IgG as the secondary Ab (Santa Cruz Biotechnology).  
vav2 phosphorylation was analyzed by immunoprecipitation of vav2 with 2 µg of 
mouse anti-human phosphotyrosine Ab (Upstate Biotechnology), followed by 
immunoblotting of the precipitated protein with a 1:500 dilution of rabbit anti-human 
vav2 (Zymed Laboratories Inc.) as the primary Ab and a 1:2000 dilution of 
HRP–conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology) as the secondary Ab. 
For normalization of the signal, aliquots of total cell lysates were subjected to 
SDS-PAGE and immunoblotted with a 1:1000 dilution of mouse anti-human Rac or 
rabbit anti-human vav2 as the primary Abs, which bind to Rac or vav2, respectively, 
independent of their phosphorylation state.  
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Figure III-1. The RGD integrin-binding domain in the P2Y2R is required for 
UTP-induced migration of 1321N1 cells. Chemotaxis of 1321N1 cells (5x104) 
transfected with the WT or RGE mutant P2Y2R or the empty vector (pLXSN) seeded in 
the upper chamber of Transwells. Lower chambers contained the indicated concentration 
of UTP or serum-free medium (control). Chemotaxis expressed as the number of cells 
that moved across the membrane was evaluated 16 h after UTP stimulation. 
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Figure III-2. The RGD domain of the P2Y2R is required for vav2 and Rac activation. 
Human 1321N1 cells expressing the WT or RGE mutant P2Y2R were serum-starved 
overnight and treated with or without 1 mM UTP for 5 min at 37 °C prior to determining 
vav2 tyrosine phosphorylation and Rac GTPase activity, as described in “Materials and 
Methods”. The data shown are representative of results from 3-4 experiments. 
 
89 
 
 p-vav2-
Total vav2 t l  
90 
 
Figure III-3. P2Y2R-mediated vav2 and Rac activation requires αv integrin activity. 
Human 1321N1 cells expressing the WT P2Y2R were incubated overnight with 10 µg/ml 
anti-α3 or anti-αvβ5 Abs, then stimulated with 100 µM UTP for 5 min at 37 °C prior to 
determining vav2 phosphorylation and Rac GTPase activity, as described in the 
“Materials and Methods”. The data shown are representative of results from 3-4 
experiments.  
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Figure III-4. Role of Go in P2Y2R-mediated vav2 and Rac activation. Human 1321N1 
cells expressing the WT P2Y2R were pretreated with PTX for 16 h in serum-free medium 
then stimulated with 100 µM UTP for 5 min at 37 °C prior to determining vav2 
phosphorylation and Rac GTPase activity, as described in the “Materials and Methods”. 
The data shown are representative of results from 3-4 experiments.     
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Figure III-5. Role of the P2Y2R RGD domain in UTP-induced Akt phosphorylation. 
Human 1321N1 cells expressing the WT or RGE mutant P2Y2R were stimulated with the 
indicated concentration of UTP for 10 min at 37 °C prior to analysis of Akt 
phosphorylation using anti-phospho-Akt Ab. The phospho-Akt band density was 
normalized to total actin and shown in the lower panel. Data shown are representative of 
results from 3 experiments.  
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 CHAPTER IV 
Activated P2Y2 receptors transiently relocate to endothelial adherens 
junctions to regulate Rac activity 
 
Abstract 
 P2Y2 nucleotide receptors (P2Y2Rs) are involved in several stages of an 
inflammatory response, including up-regulation of endothelial VCAM-1, a vascular cell 
adhesion molecule that promotes tight binding of leukocytes to endothelium, and the 
extravasation and migration of leukocytes into infected or injured tissue (Seye et al., 2004; 
Chen et al., 2006).  In migrating neutrophils, P2Y2Rs are evenly distributed on the cell 
surface and are thought to sense nucleotides released at the leading edge of a cell to 
amplify bacterial chemotactic signals (Chen et al., 2006).  In this study, we analyzed the 
distribution of P2Y2Rs in quiescent and nucleotide-activated endothelial cells.  
Activation of P2Y2Rs in human coronary artery endothelial cells (HCAEC) with the 
agonist UTP caused a rapid and transient clustering of GFP-tagged P2Y2Rs at the 
intercellular junctional zones.  Co-immunoprecipitation experiments indicated that UTP 
also caused a rapid and transient association of the P2Y2R and VEGFR-2 (vascular 
endothelial growth factor receptor-2) with VE-cadherin, a transmembrane component of 
endothelial adherens junctions. Knockdown of VE-cadherin expression with siRNA in 
HCAEC led to a loss of UTP-induced Rac activation and tyrosine phosphorylation of 
p120 catenin, a cytoplasmic protein known to interact with VE-cadherin.  Activation of 
the P2Y2R by UTP also was found to cause a prolonged interaction between p120 catenin 
and vav2 (a guanine nucleotide exchange factor for Rac) that correlated with the kinetics 
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of UTP-induced tyrosine phosphorylation of p120 catenin and VE-cadherin.  Inhibitors 
of VEGFR-2 or Src significantly diminished UTP-induced Rac activation, tyrosine 
phosphorylation of p120 catenin and VE-cadherin, and association of the P2Y2R with 
VE-cadherin and p120 catenin with vav2. These findings suggest that the P2Y2R uses Src 
and VEGFR-2 to mediate association of the P2Y2R with adherens junctions and to 
activate Rac in endothelial cells.  
 
Introduction  
Transendothelial migration of leukocytes in blood vessels is controlled by the 
formation and dissociation of endothelial cell adhesion structures comprised of adherens 
junctions, tight junctions and gap junctions (Mehta and Malik, 2006). It is well known 
that endothelial barrier function is regulated by the stability of these junctional structures 
and the contractility provided by the actomyosin cytoskeleton. Rho family GTPases 
control both the stability of intercellular junctions and actin cytoskeletal organization 
(Wojciak-Stothard and Ridley, 2002). For example, endothelial Rho GTPase and Rho 
kinase promote the sealing of intercellular junctions by controlling phosphorylation of 
myosin light chain (Saito et al., 2002). In contrast, alternative roles for other Rho family 
GTPases are suggested by studies demonstrating that dominant negative Rac enhances 
thrombin-induced permeability of macromolecules, whereas dominant negative Cdc42 
has no effects (Wojciak-Stothard et al., 2001). VEGF, thrombin, TNFα and histamine also 
can increase endothelial permeability, due to modulation of protein distribution in 
adherens junctions and the activities of Rho GTPases (Rabiet et al., 1996; Esser et al., 
1998; Kevil et al., 1998; Vouret-Craviari et al., 1998; Wojciak-Stothard et al., 1998; 
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Andriopoulou et al., 1999; Wong et al., 1999; Soga et al., 2001).  
Extracellular nucleotides have been shown to play a role in regulating blood vessel 
permeability and leukocyte infiltration. For example, extracellular ATP reduces the 
permeability of endothelial cell monolayers to macromolecules, most likely via activation 
of P2 receptors (Noll et al., 1999), whereas 2-MeSATP, an agonist of the P2Y1 receptor, 
increases endothelial monolayer permeability (Tanaka et al., 2004). A recent study has 
shown that the P2Y2R activation by ATP released at the leading edge of migrating 
neutrophils can amplify bacterial chemotactic signals that recruit neutrophils to the site of 
an infection (Chen et al., 2006). It also has been shown that local infusion of the P2Y2R 
agonist UTP into a silicone collar placed around a rabbit carotid artery promotes intimal 
hyperplasia and increases monocyte infiltration into the intimal tissue (Seye et al., 2002). 
Other studies indicate that the P2Y2R, by virtue of a RGD integrin-binding motif in its 
extracellular domain, mediates the activation of small Rho GTPases (Bagchi et al., 2005; 
Liao et al., 2007) and, by virtue of SH3-binding motifs in its intracellular domain, 
promotes the Src-dependent activation of VEGFR-2 that up-regulates the expression of 
the leukocyte binding protein VCAM-1 on endothelial cells (Liu et al., 2004; Seye et al., 
2004). Since the P2Y2R regulates both leukocyte adhesion to endothelium and Rho 
GTPase activities (Wheelock and Johnson, 2003; Seye et al., 2004; Bagchi et al., 2005; 
Liao et al., 2007), we speculated that the P2Y2R may modulate the permeability of 
endothelium to leukocytes by affecting the stability of adherens junctions. 
Among the proteins in endothelial cell junctions, VE-cadherin has been well 
recognized for its role in regulating recruitment and endothelial permeability of 
leukocytes  (Breviario et al., 1995; Gotsch et al., 1997; Matsuyoshi et al., 1997; Corada 
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et al., 1999). VE-cadherin is exclusively expressed in vascular endothelial cells (Dejana 
et al., 1999) and deletion of VE-cadherin in mice causes severe defects in vascular 
development and embryonic death (Carmeliet et al., 1999; Gory-Faure et al., 1999). 
Down-regulation of VE-cadherin has been associated with vascular tumor growth 
(Zanetta et al., 2005), whereas treatment of endothelial cells with VE-cadherin 
neutralizing antibody increases VEGF-induced VEGFR-2 activity (Rahimi and 
Kazlauskas, 1999). Compared to endothelial cells expressing VE-cadherin, 
VE-cadherin-null endothelial cells have thinner actin stress fibers, decreased 
vinculin-positive focal contacts, and attenuated activity of Rac, a small GTPase involved 
in actin reorganization and cell migration (Lampugnani et al., 2002). The N-terminal 
extracellular domain of VE-cadherin mediates Ca2+-dependent homophilic adhesion 
while the cytoplasmic domain interacts with various intracellular binding partners, 
including α-, β-, and p120 catenins, which may provide a linkage to actin cytoskeleton 
(Vincent et al., 2004).  Modulation of cell-cell contacts that regulate cell adhesion and 
cell motility likely requires interactions between cadherins and catenins. It has been 
shown that p120 catenin regulates actin cytoskeletal organization and cell motility by 
activation of Rho GTPase (Anastasiadis et al., 2000; Noren et al., 2000; Grosheva et al., 
2001). In addition, VE-cadherin may associate with VEGFR-2 and some intracellular 
signaling molecules such as Shc and Csk ( Zanetti et al., 2002; Baumeister et al., 2005), 
and protein phosphatases such as VE-PTP (vascular endothelial protein tyrosine 
phosphatase) (Nawroth et al., 2002). These interactions may be important for regulating 
cell-cell contacts, cell adhesion, and growth factor signaling (Dejana et al., 1999).  
   In the present study, we investigated the distribution of P2Y2Rs in human coronary 
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artery endothelial cells (HCAEC) and found that stimulation of the receptor with UTP 
caused clustering of P2Y2Rs at intercellular junctions, a process that was dependent on 
Src and VEGFR-2 activity. We also demonstrate that UTP causes transient association of 
the P2Y2R and VEGFR-2 with VE-cadherin.  This led us to investigate the role of 
VE-cadherin in P2Y2R-mediated signaling in endothelial cells.  These studies suggest 
that Rac activation by the P2Y2R in endothelial cells involves tyrosine phosphorylation of 
VE-cadherin and p120 catenin and association of p120 catenin with vav2, a Rac guanine 
nucleotide exchange factor (GEF).  
 
Results 
UTP causes clustering of the P2Y2R in intercellular junctions 
It has been shown that VE-cadherin inhibits the internalization of VEGFR-2 in 
response to VEGF, and thus VEGF-induced signaling (Lampugnani et al., 2006), possibly 
via interaction between VE-cadherin and VEGFR-2 (Zanetti et al., 2002). Consistent with 
this finding, we found that overexpression of VE-cadherin in 1321N1 astrocytoma cells 
expressing the wild type HA-hP2Y2R inhibited UTP-induced internalization of the 
HA-hP2Y2R (Supplemental Fig. IV-S1). To further investigate whether the P2Y2R 
redistributes in endothelial cells in response to UTP, we transfected HCAEC with cDNA 
encoding the GFP-tagged hP2Y2R and examined the localization of GFP-hP2Y2Rs in the 
absence and presence of UTP. Thirty-six hours after transfection, most GFP-hP2Y2Rs 
were localized to an intracellular compartment (not shown), possibly early endosomes, 
whereas 84 h after transfection, the GFP-hP2Y2R appeared at the peripheral cell 
membrane (Fig. IV-1). In ~50% of the transfected cells, a 5 min stimulation with UTP 
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caused clustering of GFP-hP2Y2R in peripheral membranes between adjacent cells, and 
co-localization with the adherens junction protein VE-cadherin (Fig. IV-1), suggesting 
that VE-cadherin recruits the activated GFP-hP2Y2R to junctional zones of endothelial 
cells. 
 
UTP induces transient association between VE-cadherin and the P2Y2R 
Since the P2Y2R was translocated to intercellular adherens junctions upon activation 
(Fig. IV-1), we examined whether the P2Y2R was recruited by interacting with an 
adherens junction protein. Accordingly, HCAEC were transfected with cDNA encoding 
the HA-hP2Y2R and immunoprecipitation with anti-HA matrix was performed. An 
interaction between the HA-hP2Y2R and VE-cadherin in HCAEC was observed within 5 
min of exposure to 100 µM UTP, but was not detected 10 min later (Fig. IV-2A).  
 
The P2Y2R mediates tyrosine phosphorylation of VE-cadherin   
VEGF (vascular endothelial growth factor) can stimulate the tyrosine 
phosphorylation of adherens junction proteins, including VE-cadherin, β-catenin, 
plakoglobin, and p120 catenin (Esser et al., 1998). It has been found that activation of the 
G protein-coupled P2Y2R induces the Src-dependent transactivation of growth factor 
receptors, including the EGFR, PDGFR (Liu et al., 2004) and VEGFR-2 (Seye et al., 
2004). Therefore, we hypothesized that activation of the P2Y2R would increase the 
tyrosine phosphorylation of VE-cadherin. Indeed, we found that the P2Y2R agonist UTP 
induced sustained tyrosine phosphorylation of VE-cadherin in HCAEC, as detected by 
immunoprecipitation of cell lysates with anti-phosphotyrosine antibody (Fig. IV-3A) or 
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anti-VE-cadherin (data not shown). To confirm that UTP-induced tyrosine 
phosphorylation is mediated by the P2Y2R, we suppressed expression of the endogenous 
P2Y2R in HCAEC with specific P2Y2R siRNA duplexes. Results indicated that 
down-regulation of P2Y2R mRNA expression inhibited UTP-induced tyrosine 
phosphorylation of VE-cadherin in HCAEC (Figs. 3B and 3C), demonstrating the 
involvement of the P2Y2R. In addition, expression of HA-hP2Y2R and VE-cadherin in P2 
receptor-deficient 1321N1 astrocytoma cells enabled UTP to induce tyrosine 
phosphorylation of VE-cadherin (data not shown), further supporting the ability of 
P2Y2R activation to mediate VE-cadherin phosphorylation. 
 
Src-dependent VEGFR-2 transactivation plays a role in P2Y2R-mediated tyrosine 
phosphorylation of VE-cadherin  
Since VEGFR-2 and VE-cadherin interaction is required for VEGF-induced tyrosine 
phosphorylation of VE-cadherin (Zanetti et al., 2002) and since P2Y2R activation 
promotes the Src-dependent transactivation of VEGFR-2 (Seye et al., 2004), we 
hypothesized that P2Y2R-mediated tyrosine phosphorylation of VE-cadherin in HCAEC 
is dependent on Src-dependent VEGFR-2 transactivation. P2Y2R activation by UTP 
caused a transient interaction between VE-cadherin and VEGFR-2 that decreases within 
5-15 min of UTP addition (Fig. IV-2B), similar to the kinetics of VE-cadherin and P2Y2R 
association in response to UTP (Fig. IV-2A). UTP-induced tyrosine phosphorylation of 
VE-cadherin was sustained for more than 30 min (Fig. IV-3A and data not shown), 
possibly due to auto-phosphorylation of the VEGFR-2. To further investigate the role of 
Src and VEGFR-2 in P2Y2R-mediated tyrosine phosphorylation of VE-cadherin, we 
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treated HCAEC with PP2 (1 µM) or SU1498 (10 µM), inhibitors of Src or VEGFR-2 
activity, respectively. PP2 and SU1498 inhibited both UTP-induced tyrosine 
phosphorylation of VE-cadherin (Fig. IV-4), and the UTP-induced interaction between 
the HA-hP2Y2R and VE-cadherin (Fig. IV-2C), consistent with a role for Src-dependent 
VEGFR-2 transactivation in mediating signal transduction between the P2Y2R and 
VE-cadherin.  Furthermore, a mutant hP2Y2R (Del) that lacks the C-terminal 
SH3-binding domains required for Src-dependent VEGFR-2 transactivation (Seye et al., 
2004) did not induce tyrosine phosphorylation of VE-cadherin or interaction of 
VE-cadherin with the Del-hP2Y2R in 1321N1 cells treated with UTP (Supplemental Fig. 
IV-2), demonstrating that the binding of Src to SH3-binding domains in the P2Y2R is 
required for VEGFR-2 transactivation and the stimulation of VE-cadherin 
phosphorylation. 
 
Both VE-cadherin and VEGFR-2 are required for UTP-induced Rac activation  
Recent studies have demonstrated an important role for VE-cadherin-containing 
adherens junctions in regulating cell proliferation (Grazia Lampugnani et al., 2003) and 
actin cytoskeletal organization (Lampugnani et al., 2002). To investigate the role of 
VE-cadherin in P2Y2R-mediated signal transduction, VE-cadherin-specific siRNA was 
used to down-regulate the expression of VE-cadherin in HCAEC (Fig. IV-5A). It was 
reported that the presence of VE-cadherin decreased MAPK phosphorylation in response 
to VEGF (Grazia Lampugnani et al., 2003). However, we found that P2Y2R-mediated 
MAPK (i.e., ERK1/2) activation in HCAEC was not affected by the presence of 
VE-cadherin (Fig. IV-5A). In contrast, down-regulation of VE-cadherin led to an 
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inhibition of UTP-induced activation of Rac (Fig. IV-5B). Furthermore, UTP-induced 
Rac activation in HCAEC was inhibited by PP2 or SU1498 (Fig. IV-5C), suggesting roles 
for Src and VEGFR-2 in the P2Y2R-mediated activation of Rac. Consistent with a 
previous report (Lampugnani et al., 2002), we also found that knockdown of VE-cadherin 
expression in HCAEC caused an increase in basal Rho activity, which, however, was not 
further stimulated by UTP (Supplemental Fig. IV-3). Since both UTP-induced 
phosphorylation of VE-cadherin and activation of Rac are regulated by VEGFR-2, we 
conclude that VEGFR-2 activity is required for VE-cadherin-dependent activation of Rac 
mediated by the P2Y2R. 
 
The P2Y2R regulates p120 catenin phosphorylation via VEGFR-2 and VE-cadherin 
Other adherens junction proteins that interact with VE-cadherin provide a linkage 
with actin cytoskeleton as well as intracellular signaling pathways (Vincent et al., 2004). 
Among these adherens junction proteins, p120 catenin binds to the cytoplasmic domain 
of cadherins in the juxtamembrane region and regulates the activity of small Rho 
GTPases, thereby modulating actin cytoskeletal organization and cell motility 
(Anastasiadis et al., 2000; Noren et al., 2000; Grosheva et al., 2001). Tyrosine 
phosphorylation of p120 catenin is dependent upon an interaction between p120 and 
VE-cadherin, thereby regulating endothelial barrier function (Iyer et al., 2004). We found 
that in HCAEC, UTP also caused tyrosine phosphorylation of p120 catenin, which was 
inhibited by transfection of cells wih P2Y2R-specific siRNA, indicating that 
UTP-induced phosphorylation of p120 catenin is mediated by the P2Y2R (Fig. IV-6A). 
P2Y2R-mediated tyrosine phosphorylation of p120 catenin is also prevented by treatment 
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of HCAEC with PP2 or SU1498 (Figs. IV-6B and 6C), indicating a role for 
Src-dependent VEGFR-2 transactivation in UTP-induced p120 catenin phosphorylation. 
Furthermore, down-regulation of VE-cadherin with VE-cadherin-specific siRNA 
inhibited UTP-induced tyrosine phosphorylation of p120 catenin (Fig. IV-6D), indicating 
that VE-cadherin is required for modulation of p120 catenin phosphorylation in response 
to P2Y2R activation. 
 
p120 catenin regulates P2Y2R-mediated activation of Rac  
To examine the role of p120 catenin in VE-cadherin-dependent activation of Rac 
mediated by the P2Y2R, we transfected HCAEC with p120 catenin-specific siRNA to 
down-regulate expression of p120 catenin. UTP-induced activation of Rac was inhibited 
by p120 catenin-specific siRNA transfection (Fig. IV-7), further supporting the idea that 
adherens junction proteins are necessary for the P2Y2R to modulate Rho GTPase activity. 
In addition, p120 catenin-specific siRNA also increased the basal activity of Rho in 
HCAEC, similar to VE-cadherin-specific siRNA, although no further activation by UTP 
was seen (data not shown). Previously, we found that vav2, a Rac guanine nucleotide 
exchange factor (GEF), regulated P2Y2R-mediated Rac activation, by demonstrating that 
expression of dominant negative vav2 inhibits Rac activity in UTP-treated 1321N1 cells 
expressing the P2Y2R (Bagchi et al., 2005). It has been postulated that vav2 binding to 
p120 is required for P2Y2R-mediated Rac activation (Noren et al., 2000). We found that 
UTP increased the interaction between p120 catenin and vav2 in HCAEC (Fig. IV-8A), 
supporting the conclusion that vav2 interaction with p120 catenin is necessary for 
P2Y2R-mediated activation of Rac. Furthermore, the UTP-induced interaction of vav2 
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and p120 catenin was inhibited by SU1498 or PP2 (Fig. IV-8B), consistent with a role for 
Src-dependent VEGFR-2 activation in P2Y2R-mediated Rac activity. 
 
Discussion 
In contrast to the uniform distribution of P2Y2Rs in migrating neutrophils (Chen et 
al., 2006), we found that stimulation of human coronary artery endothelial cells (HCAEC) 
with the P2Y2R agonist UTP promotes a rapid and transient re-distribution of 
GFP-tagged P2Y2Rs into intercellular junctions (Fig. IV-1). This correlated with the rapid 
and transient association of the P2Y2R with VE-cadherin (Fig. IV-2A), an endothelial 
cell-specific component of intercellular adherens junctions that is important for the 
regulation of endothelial barrier functions.   
 Association of the P2Y2R with VE-cadherin induced by UTP was prevented by 
pretreatment of the cells with PP2 or SU1498, compounds that inhibit Src and VEGFR-2 
activity, respectively (Fig. IV-2C), suggesting that Src and VEFGR-2 mediate P2Y2R 
signaling in endothelial adherens junctions.  In support of this finding, UTP also caused 
a rapid and transient association of VEGFR-2 with VE-cadherin (Fig. IV-2B) and the Src- 
and VEGFR-2-dependent tyrosine phosphorylation of VE-adhering (Fig. IV-4) and the 
VE-cadherin-associated protein, p120 catenin (Figs. IV-6B and 6C).  VEGFR-2 has also 
been found to associate with VE-cadherin in response to shear stress in vascular 
endothelial cells (Shay-Salit et al., 2002).  Since nucleotides are known to be released in 
response to mechanical stress (Born and Kratzer, 1984), this suggests that the P2Y2R and 
other nucleotide receptors act as shear stress receptors in the vasculature.   
VEGF and the GPCR ligands thrombin, histamine and sphingosine-1-phosphate 
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(S1P) have been shown to regulate changes in endothelial permeability via modulation of 
VE-cadherin function (Rabiet et al., 1996; Andriopoulou et al., 1999; Sanchez et al., 
2007).  Although we did observe an increase in endothelial permeability to 
FITC-labeled dextran after UTP treatment, the increase in permeability occurred only 
after 12 h incubation with UTP and may be related to the increase in VEGF expression 
caused by UTP treatment (data not shown), whereas VEGF-, thrombin-, histamine- and 
S1P-induced permeability changes occurred within the first hour of treatment (Rabiet et 
al., 1996; Andriopoulou et al., 1999; Sanchez et al., 2007).   This suggests that the 
function of the P2Y2R in endothelial cells is not to regulate vascular permeability to 
macromolecules.  Based on results presented in this study, we hypothesize that one 
function of endothelial P2Y2Rs may be to escort leukocytes to paracellular junctions.   
Previous studies in endothelial cells indicate that UTP treatment causes a transient 
association of the P2Y2R with VEGFR-2 (Liu et al., 2004; Seye et al., 2004).  This 
association is accompanied by tyrosine phosphorylation of VEGFR-2 and up-regulation 
of the leukocyte binding protein VCAM-1, a process that is dependent on VEGFR-2 
expression and kinase activity (Liu et al., 2004; Seye et al., 2004).  In addition, the 
mechanism of this transactivation process has been shown to involve binding of Src to 
SH3-binding domains in the P2Y2R cytoplasmic tail, which promotes the Src-dependent 
association of P2Y2R with several growth factor receptors, including EGFR, PDGFR and 
VEGFR-2 (Liu et al., 2004; Seye et al., 2004).  In this study, we used selective inhibitors 
of VEGFR-2 (SU1498) and Src (PP2) and found that, in HCAEC, VEGFR-2 and Src 
kinase activity are required for UTP-induced association of the P2Y2R with VE-cadherin 
as well as tyrosine phosphorylation of VE-cadherin and the VE-cadherin-associated 
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protein p120 catenin, and the association of the Rac GTP exchange factor vav2 with p120 
catenin leading to Rac activation (Fig. IV-9). Furthermore, we found that 
down-regulation of VE-cadherin expression with specific siRNA abolished UTP-induced 
phosphorylation of p120 catenin and Rac activation and that down-regulation of p120 
catenin inhibited UTP-induced Rac activation in HCAEC. Together, these results 
demonstrate that in HCAEC, P2Y2R-mediated activation of Rac requires Src-dependent 
transactivation of VEGFR-2, which is responsible for proper assembly of proteins 
involved in Rac activation at adherens junctions.   
Although the ultimate function of Rac activation by the P2Y2R in quiescent 
endothelial cells is unclear, it is known that Rac participates in cytoskeletal 
rearrangements important for endothelial permeability (Wojciak-Stothard et al., 2001) 
and transendothelial migration of leukocytes (van Wetering et al., 2003) and there is 
evidence indicating that the P2Y2R is involved in leukocyte migration and extravasation 
during inflammation. For example, introduction of the P2Y2R agonist UTP via a vascular 
collar placed around a rabbit carotid artery, caused a 4-fold increase in monocyte 
migration into the neointima (Seye et al., 2002). Also, P2Y2R–/– mice are defective in the 
recruitment of neutrophils towards a site of bacterial infection in vivo (Chen et al., 2006).  
The present study demonstrates that VE-cadherin is required for Rac activation mediated 
by the P2Y2R in endothelial cells, which likely regulates actin cytoskeletal 
rearrangements important for transendothelial migration of leukocytes.  
VE-cadherin interacts homophilically between neighboring endothelial cells. This 
interaction is reduced during angiogenesis and leukocyte extravasation and it is well 
established that VE-cadherin serine and tyrosine phosphorylation regulates VE-cadherin 
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endocytosis and adherens junction integrity in response to VEGFR-2 activation by VEGF 
(Gavard and Gutkind, 2006; Mukherjee et al., 2006). We found that UTP treatment 
caused tyrosine phosphorylation of VE-cadherin and the VE-cadherin-associated protein, 
p120 catenin (Figs. IV-3 and 6), but did not significantly alter the distribution of 
VE-cadherin in endothelial cells after 5 min (Fig. IV-1) or 30 min (data not shown), 
suggesting that the P2Y2R does not regulate VE-cadherin endocytosis.  
Besides VEGFR-2, integrins such as αvβ3/β5 may also play a role in regulating 
P2Y2R/VE-cadherin interactions. It has been shown that fibronectin binding to integrins 
disrupts VE-cadherin-containing adherens junctions in a Src-dependent manner (Wang et 
al., 2006). The P2Y2R contains a RGD domain that promotes interactions with αvβ3/β5 
integrins (Erb et al., 2001)  and when mutated to RGE, the RGE-P2Y2R mutant did not 
exhibit UTP-induced phosphorylation of VE-cadherin(date not shown), suggesting that 
P2Y2R/integrin interactions play a role in signaling to VE-cadherin. 
The role of VE-cadherin in controlling cell proliferation has been well recognized, 
and requires interactions between VE-cadherin and the cell cytoskeleton, Src kinases, and 
catenins (Ferber et al., 2002; Nelson and Chen, 2003; Baumeister et al., 2005). 
VE-cadherin also regulates cell proliferation by preventing VEGF-induced internalization 
of VEGFR-2 that is required for activation of the mitogen-activated protein kinases 
ERK1/2 (Lampugnani et al., 2006). We found that overexpression of VE-cadherin in 
1321N1 cells stably expressing the HA-tagged P2Y2R inhibits UTP-induced 
internalization of the P2Y2R (Supplemental Fig. IV-S1). Unlike Rac activation, however, 
UTP-induced ERK1/2 activation was unaffected by either down-regulation (Fig. IV-5) or 
overexpression of VE-cadherin (data not shown). Since the Gq-coupled P2Y2R has been 
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reported to couple to other G proteins, including Go and G12 that regulate 
P2Y2R-mediated activation of Rho GTPases in an integrin-dependent manner (Bagchi et 
al., 2005; Liao et al., 2007), it is likely that specific G proteins also regulate 
P2Y2R/VE-cadherin interactions.  
Since UTP-induced tyrosine phosphorylation of p120 catenin is dependent on the 
presence of VE-cadherin (Fig. IV-6D), we conclude that p120 catenin acts downstream of 
VE-cadherin to regulate Rac activity.  Furthermore, we found that the UTP-induced 
interaction between p120 catenin and the Rac GEF, vav2, occurs in a 
VEGFR-2-dependent manner (Fig. IV-8), thereby elucidating a novel pathway by which 
the P2Y2R regulates Rac activity. 
In summary, results presented here indicate that in endothelial cells, activation of 
the G protein-coupled P2Y2R induces the Src- and VEGFR-2-dependent activation of 
VE-cadherin in adherens junctions, which leads to the p120 catenin- and vav2-dependent 
activation of Rac (Fig. IV-9). Since the P2Y2R can associate with VE-cadherin (Fig. IV-2) 
as well as VEGFR-2 (Seye et al., 2004) and αvβ3/β5 integrins (Erb et al., 2001), these 
results suggest that the P2Y2R participates in a multi-receptor complex to regulate the 
function of adherens junctions.  This study elucidates a novel mechanism whereby a 
GPCR can modulate adherens junctions that regulate actin cytoskeletal rearrangements 
and leukocyte infiltration into endothelium, responses that initiate vascular inflammation 
in cardiovascular diseases. 
 
Materials and Methods 
Materials  
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Goat anti-human VE-cadherin polyclonal antibody, rabbit anti-human 
Flk-1(VEGFR-2) polyclonal antibody, and rabbit anti-vav2 polyclonal antibody were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The mouse 
anti-phosphotyrosine antibody was purchased from BD Bioscience (San Jose, CA). 
Mouse anti-HA antibody conjugated agarose beads and rabbit anti-HA antibody were 
purchased from Covance (Berkeley, CA). Anti-p120 catenin antibodies were purchased 
from Santa Cruz Biotechnology and BD Bioscience. Rabbit polyclonal 
anti-phospho-ERK1/2 antibody was purchased from Cell Signaling (Beverly, MA). 
Specific inhibitors for VEGFR-2 tyrosine phosphorylation (SU1498) and Src (PP2) were 
obtained from Calbiochem (Indianapolis, IN). ON-TARGETplus SMARTpool siRNA 
duplexes targeting the human P2Y2 receptor, VE-cadherin and p120 were purchased from 
Dharmacon (Chicago, IL). VE-cadherin cDNA was a kind gift from Dr.  Elisabetta 
Dejana (IFOM-IEO, Milan, Italy). All other reagents including nucleotides were obtained 
from Sigma-Aldrich (St. Louis, MO), unless otherwise specified.  
 
Cell Culture and Transfection 
HCAEC (human coronary artery endothelial cells) were cultured in endothelial basal 
medium-2 (EBM-2; Clonetics, Walkerville, MD) at 37 °C in a humidified atmosphere of 
5% CO2 and 95% air. HCAEC were used between the fourth and eighth passages. For 
transient transfections, siRNA or plasmid constructs were delivered using Targefect F-2 
plus Virofect or Targefect-HUVEC from Targeting Systems (Santee, CA), respectively, 
according to the manufacturer’s instructions. In both cases, transfection efficiency of at 
least 60% was achieved. Human P2Y2R (hP2Y2R) cDNA encoding a hemagglutinin (HA) 
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tag at the N-terminus in pcDNA3.1(–) (Liao et al., 2007) or cDNA encoding the hP2Y2R 
cDNA with an eGFP tag at the C-terminus in pEGFP-N1 (a kind gift from Dr. Fernando 
A. González, Department of Chemistry, University of Puerto Rico) were transiently 
expressed in HCAEC. Human 1321N1 astrocytoma cells lacking endogenous P2 
receptors were also used in supplemental experiments. The cells were cultured in 
Dulbecco's modified Eagle's medium (DMEM; Invitrogen, CA) containing 5% (v/v) fetal 
bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin and maintained at 
37 °C in a humidified atmosphere of 5% CO2 and 95% air. Cells were stably transfected 
with cDNA encoding either the wild-type P2Y2Rs or a mutant P2Y2R in which the 
C-terminal proline-rich SH3-binding domains where deleted (Del), as previously 
described (Liu et al., 2004) . These receptor constructs contained sequence encoding a HA 
tag at the N-terminus of the P2Y2R, as previously described (Liu et al., 2004). In addition, 
the cells were transiently transfected with either pcDNA3 vector or pcDNA-VE-cadherin 
using the Lipofectamine 2000 reagent (Invitrogen, CA).  
 
Confocal Laser Scanning Microscopy Visualization 
HCAEC plated on glass coverslips were cultured to ~90% confluence before being 
transfected with hP2Y2R-eGFP cDNA. The cell transfectants were maintained in growth 
medium for 72 h and transferred to serum-free medium for 12 h. Then, cells were 
incubated with or without 100 µM UTP for 5 min at 37 °C, washed in ice-cold PBS, fixed 
for 10 min in 4% (w/v) paraformaldehyde, treated with 0.1% (v/v) Triton X-100 for 5 
min, and rinsed in PBS. Fixed cells were incubated with mouse anti-human VE-cadherin 
antibody (1:100 dilution, BD Bioscience, CA) for 1 h, washed and stained with Alexa 
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Fluor 594 goat anti-mouse IgG (1:200 dilution, Invitrogen) for 1 h, followed by 
incubation with Hoechst (Invitrogen). Coverslips were mounted on glass slides in 
ProLong antifade reagent (Invitrogen) and examined using a Zeiss inverted LSM 510 
META confocal laser scanning microscope (CLSM) equipped with a C Apochromat 40X 
objective. Images were acquired, processed and analyzed with a Zeiss LSM Image 
Examiner.  
 
RNA Extraction and RT-PCR 
Isolation of RNA, cDNA synthesis, and RT-PCR were performed as previously 
described (Schrader et al., 2005). Amplification of P2Y2R cDNA was performed by 
RT-PCR using the following oligonucleotide primers:  sense 
5’-CTTCAACGAGGACTTCAAGTACGTGC-3’, and antisense 5’-CATGT 
TGATGGCGTTGAGGGTGTGG-3’. Primers for amplification of human G3PDH cDNA 
were: sense 5'-TGAAGGTCGGAGTCAACGGATTTGGT-3', and antisense 
5'-CATGTGGGCCATGAGGTCC ACCAC-3'. Thirty-five amplification cycles were used, 
with annealing temperatures of 60 °C as previously described (Schrader et al., 2005). 
PCR products were resolved by 2% (w/v) agarose gel electrophoresis. 
 
Rac activity assay 
A Rac activation assay kit (Upstate Biotechnology, NY) was used to assess Rho 
activity according to the manufacturer's instructions. Briefly, cells were cultured in 6-well 
tissue culture dishes in EBM-2 with all supplements and then transferred to serum-free 
medium for 12 h before incubation with or without UTP for 5 min at 37 °C. Then, cells 
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were washed three times with ice-cold PBS, suspended in Lysis Buffer containing 125 
mM HEPES, pH 7.5, 750 mM NaCl, 5% (v/v) Igepal CA-630, 50 mM MgCl2, 5 mM 
EDTA and 10% (v/v) glycerol, and the lysates were transferred to 1.5 ml tubes. Thirty 
microliters of agarose-conjugated p21 binding domain of PAK-1 that only recognizes 
GTP-bound Rac were added to 500 µl of lysate for 1 h at 4 °C. The beads were collected 
by centrifugation and washed three times with Lysis Buffer. Finally, the beads were 
resuspended in 40 ml of 2X Laemmli sample buffer (120 mM Tris-HCl, pH 6.8, 2% (w/v) 
SDS, 10% (w/v) sucrose, 1 mM EDTA, 50 mM dithiothreitol and 0.003% (w/v) 
Bromophenol Blue) and Western analysis (see below) was performed with a 1:1000 
dilution of mouse anti-human Rac antibody (Upstate Biotechnology, NY). In some 
experiments (see supplemental data), Rho activity was determined similarly except that 
p21-PAK-1-agarose and anti-Rac antibody were replaced with Rhotekin Rho binding 
domain (RBD)-agarose and mouse anti-human Rho antibody (Upstate Biotechnology, 
NY), respectively. 
 
Immunoprecipitation and Immunoblotting 
Immunoprecipitation (IP) and immunoblotting (IB) were performed, as previously 
described (Liao et al., 2007). Lysates from HCAEC were used for immunoprecipitation 
(IP) with the indicated antibodies, as previously described (Liao et al., 2007). The 
immune complexes were precipitated with protein A- or protein G-conjugated beads and 
analyzed by IB with antibodies against the proteins of interest. After IB, the membrane 
was stripped and reprobed with the same antibody used for IP. IP also was performed 
with lysates from cells expressing the HA-hP2Y2R using anti-HA-conjugated agarose 
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beads. These immunoprecipitated samples were analyzed by IB with anti-VE-cadherin or 
anti-HA antibody, respectively. 
 
Internalization of HA-hP2Y2R  
Internalization of the HA-hP2Y2R was examined indirectly by determining the 
uptake of HA antibodies added into 1321N1 astrocytoma cells stably expressing the wild 
type HA-hP2Y2R, as described (Mao et al., 2007). Briefly, the cells were transfected with 
either pcDNA3 or pcDNA3-VE-cadherin. Then, cell transfectants were incubated at 37 
°C in serum-free medium supplemented with 5 µg/ml anti-HA antibodies in the absence 
or presence of 1 mM UTP for 5 min to allow endocytosis of anti-HA antibody bound to 
the HA-hP2Y2R. Cells were then placed on ice to prevent further receptor internalization, 
washed with ice-cold PBS, and surface-bound antibodies were removed by three washes 
with ice-cold acidic buffer (100 mM glycine, 20 mM magnesium acetate, 50 mM 
potassium chloride, pH 2.2). After an additional wash with ice-cold PBS, the cells were 
lysed with 2X Laemmli sample buffer, and lysates were analyzed for anti-HA antibodies 
by immunoblotting. Anti-HA antibodies were detected by chemiluminescence using 
horseradish peroxidase-conjugated antibodies (1:1000 dilution). 
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Figure IV-1. UTP causes clustering of the eGFP-P2Y2R in intercellular junctions in 
HCAEC. (A) HCAEC were transiently transfected with eGFP-tagged P2Y2R cDNA 
(shown in green) in pEGFP-N1, as described in “Materials and Methods”. Then, 72 h 
after transfection, the cells were serum-starved for 12 h and stimulated with 100 µM UTP 
for 5 min at 37 °C . Cells were washed, fixed, permeabilized and stained with mouse 
anti-VE-cadherin antibody. Alexa Fluor 594-conjugated anti-mouse IgG and Hoechst 
were then used to localize VE-cadherin (shown in red) and nuclei (shown in blue), 
respectively. (B) A line (yellow) was drawn through the highly fluorescent cells shown in 
the upper panels of Fig. IV-1A (-/+ UTP). Staining densities of VE-cadherin (red curve) 
and eGFP-P2Y2R (green curve) along the line are shown below. For each treatment, ~30 
cell transfectants from 4 independent experiments were examined. 
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Figure IV-2. UTP-induced interaction between the HA-P2Y2R, VE-cadherin and 
VEGFR-2. (A) HCAEC were transfected with HA-P2Y2R cDNA in pcDNA3.1(-), as 
described in “Materials and Methods”. Then, 36 h after transfection, the cells were 
serum-starved for 12 h and stimulated with 100 µM UTP at 37 °C for the indicated time. 
Cell lysates were prepared and subjected to IP with mouse anti-HA antibody conjugated 
to agarose beads and IB with anti-VE-cadherin or rabbit anti-HA antibody. (B) HCAEC 
were serum-starved for 12 h and stimulated with 100 µM UTP at 37 °C for the indicated 
time. Cell lysates were prepared and subjected to IP with anti-VEGFR-2 antibody and IB 
with anti-VE-cadherin antibody. The membrane was stripped and re-blotted with 
anti-VEGFR-2 antibody. (C) HCAEC were transfected with HA-tagged P2Y2R in 
pcDNA3.1(-), serum-starved for 12 h and treated with PP2 (1 µM) or SU1498 (10 µM) 
for 1 h followed by incubation with or without 100 µM UTP for 5 min at 37 °C. Cell 
lysates were prepared and subjected to IP with anti-HA matrix beads and IB with 
anti-VE-cadherin or anti-HA antibody. Cell lysates also were subjected to IB with 
anti-VE-cadherin antibody to detect total VE-cadherin. Blots representative of three 
experiments are shown.  
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Figure IV-3. UTP induces tyrosine phosphorylation of VE-cadherin. (A) HCAEC 
were treated with UTP (100 µM) at 37 °C for the indicated time. Cell lysates were 
subjected to IP with anti-phosphotyrosine antibody and IB with anti-VE-cadherin 
antibody. Cell lysates also were subjected to IB with anti-VE-cadherin antibody to 
detect total VE-cadherin. (B) HCAEC were transfected with either scrambled siRNA 
or P2Y2R-specific siRNA. Then, 36 h after transfection, total RNA was extracted 
from cell lysates and RT-PCR was performed with either P2Y2R primers or G3PDH 
primers, as described in “Materials and Methods”. (C) HCAEC were transfected with 
either scrambled siRNA or P2Y2R siRNA. Then, 36 h after transfection, the cells were 
serum-starved for 12 h and incubated with or without 100 µM UTP for 5 min at 37 °C. 
Cell lysates were prepared and subjected to IP with anti-phosphotyrosine antibody and 
IB with anti-VE-cadherin antibody. The data shown are representative of results from 
three experiments. 
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Figure IV-4. Inhibitors of Src or VEGFR-2 prevent P2Y2R-mediated tyrosine 
phosphorylation of VE-cadherin. HCAEC were pretreated for 1 h at 37 °C in 
serum-free medium with or without (A) the Src kinase inhibitor PP2 (1 µM) or (B) the 
VEGFR-2 inhibitor SU1498 (10 µM), and then stimulated with or without 100 µM 
UTP for 5 min at 37 °C. Cell lysates were prepared and subjected to IP with 
anti-phosphotyrosine antibody and IB with anti-VE-cadherin antibody. Cell lysates 
also were subjected to IB with anti-VE-cadherin antibody to detect total VE-cadherin. 
Blots representative of 3 experiments are shown. 
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Figure IV-5. VE-cadherin is necessary for Src- and VEGFR-2- dependent 
activation of Rac, but not MAPK, induced by UTP. (A,B) HCAEC were 
transfected with either scrambled siRNA or VE-cadherin-specific siRNA. Then, 36 h 
after transfection, (A) cells were incubated with or without 100 µM UTP at 37 °C for 
the indicated time. Cell lysates were prepared and analyzed by IB with either 
anti-VE-cadherin antibody or anti-phospho-p42/44 (ERK1/2) antibody. (B) 
Transfected cells were subjected to a Rac activity assay, as described in the “Materials 
and Methods”. (C) HCAEC were serum-starved for 12 h, treated with or without PP2 
(1 µM) or SU1498 (10 µM) for 1 h, and then incubated with or without 100 µM UTP 
for 5 min at 37 °C prior to Rac activity assay. Cell lysates also were subjected to IB 
with anti-Rac antibody to detect total Rac. Blots representative of 3 experiments are 
shown. 
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Figure IV-6. VE-cadherin is required for P2Y2R-mediated tyrosine 
phosphorylation of p120 catenin that is dependent upon VEGFR-2. HCAEC were 
transfected with the indicated siRNA (A, D). Then, 36 h after transfection, cells were 
serum-starved for 12 h and incubated with or with 100 µM UTP for 5 min at 37 °C. 
(B,C) HCAEC were preteated with (B) PP2 (1 µM) or (C) SU1498 (10 µM) for 1 h, 
and then incubated with or without 100 µM UTP for 5 min at 37 °C. (A-D) Cell 
lysates were prepared and subjected to IP with anti-phosphotyrosine antibody and IB 
with anti-p120 catenin antibody. Cell lysates also were subjected to IB with anti-p120 
catenin antibody to detect total p120 catenin. Blots representative of 3 experiments 
are shown. 
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Figure IV-7. p120 catenin is required for UTP-induced activation of Rac. HACEC 
was transfected with either scrambled siRNA or p120 catenin-specific siRNA. Then, 
36 h later, cells were serum-starved for 12 h and incubated with or without 100 µM 
UTP for 5 min at 37 °C prior to Rac activity assay. Cell lysates were prepared and 
subjected to IB with anti-p120 catenin antibody. Blots representative of 3 experiments 
are shown. 
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Figure IV-8. UTP causes a VEGFR-2-dependent interaction between p120 
catenin and vav2. (A) HCAEC were incubated with 100 µM UTP at 37 °C for the 
indicated times. (B) HCAEC were serum-starved for 12 h, treated with or without PP2 
(1 µM) or SU1498 (10 µM) for 1 h, and then incubated with or without 100 µM UTP 
for 5 min at 37 °C. (A, B) Cell lysates were prepared and subjected to IP with 
anti-vav2 antibody and IB with anti-p120 catenin or anti-vav2 antibody. Blots 
representative of 3 experiments are shown. 
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Figure IV-9. VE-cadherin is required for VEGFR-2-dependent activation of Rac 
mediated by P2Y2R. In endothelial cells exposed to UTP/ATP, activated P2Y2R 
relocalizes to intercellular junctions by interacting with VE-cadherin, an endothelial 
specific component of intercellular adherens junctions that is necessary for 
UTP-indunced activation of Rac. Src-dependent VEGFR-2 activation is required for 
UTP/ATP-induced association of the P2Y2R with VE-cadherin as well as tyrosine 
phosphorylation of VE-cadherin and the VE-cadherin-associated protein p120 catenin, 
and the association of the Rac GTP exchange factor vav2 with p120 catenin leading to 
Rac activation. 
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Supplemental Figure IV-S1. VE-cadherin inhibits UTP-induced internalization 
of the HA-hP2Y2R in 1321N1 astrocytoma cells. Human 1321N1 astrocytoma cells 
stably expressing the wild type HA-hP2Y2R were transiently transfected with 
pcDNA3 or pcDNA3-VE-cadherin. Anti-HA antibodies were added to the medium 
and the cells were incubated with or without 1 mM UTP for 5 min at 37 °C to allow 
endocytosis to proceed. Surface-bound antibodies were removed from cells by acidic 
buffer wash and internalized anti-HA antibodies were detected by immunoblotting, as 
described in “Materials and Methods”. Total cell lysates also were subjected to 
immunoblotting with anti-VE-cadherin or anti-actin antibodies. 
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Supplemental Figure IV-S2. The Src-binding domain of the P2Y2R is required 
for the P2Y2R to interact with and phosphorylate VE-cadherin. Human 1321N1 
cells expressing the HA-tagged WT (wild type) or Del (deletion of prolines in the 
Src-binding domains) mutant hP2Y2R were transfected with VE-cadherin cDNA in 
pcDNA3. Cells were serum-starved for 12 h and incubated with or without 100 µM 
UTP for 5 min at 37 °C. Cell lysates were prepared and subjected to IP with (A) 
anti-HA matrix or (B) anti-phosphotyrosine antibody, and IB with anti-VE-cadherin 
antibody. Cell lysates also were prepared and analyzed by immunoblotting with 
anti-VE-cadherin antibody. Blots representative of 3 experiments are shown. 
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Supplemental Figure IV-S3. Effect of down-regulation of VE-cadherin on 
UTP-induced activation of Rho in HCAEC. HCAEC were transfected with either 
scrambled or VE-cadherin-specific siRNA. Then, 36 h after transfection, cells were 
serum-starved for 12 h and incubated with or without the indicated concentration of UTP 
for 5 min at 37 °C prior to performing a Rho activity assay, as described in “Materials 
and Methods”. Cell lysates also were prepared and analyzed by immunoblotting with 
anti-Rho antibody. Blots representative of 3 experiments are shown. 
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                           CHAPTER V 
Summary and future directions 
 
1. Summary 
Extracellular nucleotides have been recognized for their roles in the development of 
various chronic inflammatory diseases including vascular inflammation. Leukocyte 
emigration from the blood stream to the site of infection or injury is a major step in the 
early stages of many inflammatory diseases, a step that involves the processes of 
endothelium-dependent leukocyte adhesion, transendothelial migration, and chemotaxis. 
The fact that mechanical and pathological insults cause release of extracellular 
nucleotides from vascular endothelial cells and leukocytes triggers interest in research to 
define the role of extracellular nucleotides in mediating leukocyte recruitment into 
vascular tissue.  
Effects of extracellular nucleotides are mediated by cell surface receptors belonging 
to two families – the ligand-gated ion channels, P2XRs, and the G protein-coupled 
receptors, P2YRs.  In a study of stress-induced vascular injury, a silicone collar was 
placed around a rabbit carotid artery causing a dramatic increase in P2Y2R mRNA 
expression in endothelial and smooth muscle cells (Seye et al., 2002). Introduction of the 
P2Y2R agonist UTP into the collar, caused intimal thickening, indicative of atherogenesis, 
as well as a 4-fold increase in leukocyte migration into the intima, suggesting a potential 
role for the endothelial cell P2Y2R in monocytes recruitment in the inflammatory process 
(Seye et al., 2002). 
As reviewed in Chapter I, the P2Y2R contains a consensus integrin-binding domain 
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(RGD sequence) in the first extracellular loop, enabling it to interact with αvβ3/5 integrins 
(Erb et al., 2001). It also has consensus Src-homology-3 (SH3) binding sites in the 
intracellular C-terminal tail that bind directly to Src and allow the P2Y2R to interact with 
and transactivate several growth factor receptors including the vascular endothelial 
growth factor receptor-2 (VEGFR-2/Flk-1) (Liu et al., 2004; Seye et al., 2004). 
The overall aim of the research described in this dissertation is to understand the 
mechanisms involved in extracellular nucleotide-induced leukocyte emigration during 
vascular inflammation. It is important to learn how the P2Y2R mediates cell cytoskeletal 
rearrangements and subsequent chemotaxis, and how the P2Y2R coordinates with 
adherens junction proteins to regulate endothelial cell signaling and leukocyte 
transendothelial migration in response to extracellular nucleotides released from stressed 
or damaged tissue. Towards this aim, the results presented in this dissertation have led to 
the following novel conclusions: 
1) Interaction with αv integrin via the RGD motif in the P2Y2R is required for the 
P2Y2R to mediate cell chemotaxis and accompanying cytoskeletal 
rearrangements. 
2) Interaction with αv integrin is required for the P2Y2R to access and activate Go 
and G12, but not Gq proteins. 
3) Coupling to Go and G12 proteins enables the P2Y2R to mediate activation of Rac 
and Rho small GTPases, respectively, thereby regulating the activities of different 
downstream effectors that coordinately contribute to cell chemotaxis. 
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4) Activation of the P2Y2R in endothelial cells leads to tyrosine phosphorylation of 
adherens junction proteins, including VE-cadherin and p120 catenin, via the 
Src-dependent transactivation of VEGFR-2. 
5) Upon stimulation, the P2Y2R transiently translocates to endothelial intercellular 
junctions and interacts with VE-cadherin, suggesting a potential role for the 
P2Y2R in regulating leukocyte transendothelial migration. 
6) VE-cadherin is required for P2Y2R-mediated activation of Rac in endothelial cells, 
possibly by regulating p120 interaction with the RhoGEF, vav2. 
Although the cell chemotaxis study was performed in an astrocytoma cell line where 
no endogenous P2 receptors are present, the ability to express wild type or mutant 
P2Y2Rs in a null background has shed light on the general mechanism involved in 
P2Y2R-mediated cell chemotaxis. Since neutrophils express both P2Y2Rs and αvβ3 
integrins (Rainger et al., 1999; Chen et al., 2006), it is likely that extracellular 
nucleotide-induced neutrophil chemotaxis during inflammation is also regulated by 
interactions between these two receptors. Immune cells have to transmigrate quickly 
through the endothelium via paracellular junctions before the migration to extravascular 
tissues occurs. Interestingly, in the presence of extracellular nucleotides, the endothelial 
P2Y2R transiently interacts with VE-cadherin and, instead of being internalized, is 
recruited to endothelial adherens junctions. The interaction between the P2Y2R and 
VE-cadherin in endothelial cells is also required for activation of Rac, a Rho GTPase that 
modulates cellular structures regulating the permeability of endothelium to macro- 
molecules and leukocytes (van Wetering et al., 2003), suggesting a direct role for the 
143 
 
P2Y2R in vascular inflammation. Taken together, the results presented in this dissertation 
demonstrate that the P2Y2R associates within a multi-protein complex that includes αv 
integrin, growth factor receptors, and VE-cadherin to regulate cell chemotaxis and 
cytoskeletal reorganizations by controlling Rho GTPase activities.  
 
2. Future directions 
A. Further delineate the mechanism of P2Y2R-mediated chemotaxis 
In chapters II and III, we have demonstrated that the P2Y2R requires αv integrins to 
activate certain G proteins required for cell migration (i.e., Go, which activates Rac, and 
G12, which activates Rho). However, it is unclear how these signals are temporally and 
spatially regulated. For example, it is known that the P2Y2R remains evenly distributed 
along the peripheral membrane in a migrating cell (Chen et al., 2006), whereas Rac 
redistributes to the front and Rho redistributes to the rear of a migrating cell (Sander et al., 
1999). Therefore, it is very likely that the P2Y2R regulates these downstream signals via 
temporal and spatial controls. Our preliminary results indicate that Go and G12 do not 
distribute differentially along cells exposed to a UTP gradient, but we have technical 
concerns that our method did not detect the endogenous active form of these G proteins. 
However, other activated signaling molecules (e.g., PI3K, vav2, p115 RhoGEF), 
including those associated with the P2Y2R (αv integrin) could be detected using specific 
antibodies raised against their activated forms and this approach should be pursued. 
Follow-up studies also should be conducted with isolated neutrophils, or a differentiated 
neutrophil cell line, since astrocytoma cells do not polarize during migration to the same 
extent as neutrophils. 
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To explore spatial signaling during chemotaxis, various molecules could be labeled 
with antibodies against their activated forms in a neutrophil model (e.g., 
DMSO-differentiated HL-60 cells).  Those antibodies could include anti-phospho-PI3K, 
anti-phospho-vav2, anti-phospho-FAK, anti-phospho-PAK, anti-phospho-β3 integrin, and 
WOW-1 (anti-activated αvβ3 integrin antibody). The cells would be examined at uniform 
concentrations of UTP/ATP or in a UTP/ATP gradient achieved by micropipette delivery. 
Meanwhile, PHAKT-GFP (the GFP-tagged pleckstrin homology domain of the Akt 
protein kinase) or Gβ-GFP could be transfected into the cells to indicate the direction of 
polarization and migration. 
Furthermore, neutrophils isolated from wild type and P2Y2R knockout (P2Y2R-/-) 
mice could be used to unambiguously determine the role of the P2Y2R in regulating the 
activation and distribution of these signaling molecules.  
 
B. Identification and characterization of novel P2Y2R-associated proteins in endothelial 
cells and leukocytes. 
Different cells have different profiles of gene expression and therefore may use 
different signaling pathways to the same downstream protein target. For example, the 
P2Y2R inhibits cell spreading and migration in human keratinocytes via Gq/11 (Taboubi et 
al., 2007), rather than Gi/o or G12/13. Since the P2Y2R interacts with growth factor 
receptors and αv integrins, we speculate that the P2Y2R may be a component of a large 
signaling complex containing integrins and integrin-associated proteins such as pyk2, Src, 
FAK, growth factor receptors and actin cytoskeletal proteins. A better understanding of 
the nature of these multi-protein interactions and signaling events involving P2Y2Rs will 
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likely identify intervention points for selectively controlling P2Y2R activities that 
mediate inflammatory responses, leading to new treatments for inflammatory disorders, 
such as atherosclerosis, diabetes, neurodegenerative disorders, cancer, and ulcers.   
To identify novel P2Y2R-associated proteins, plasmids contain HA-tagged or 
GFP-tagged P2Y2R cDNA would be transfected into neutrophils or endothelial cells. 
After immunoprecipitation with specific antibodies (e.g., anti-HA or anti-GFP antibody), 
the immunoprecipitated products can be analyzed by SDS-PAGE or 2D electrophoresis. 
By use of mass spectrometry, we may be able to identify proteins having transient or 
sustained interactions with the activated P2Y2R. 
To characterize the function of these interacting proteins in P2Y2R-mediated 
signaling and cell migration, specific inhibitors or RNA interference could be used to 
functionally down-regulate these proteins. In addition, these P2Y2R-interacting proteins 
can be examined for their post-translational modifications in response to activation of the 
P2Y2R. Immunostaining of these proteins in migrating cells could give insight into how 
the P2Y2R regulates chemotactic signals spatially.  
 
C. Determine whether the P2Y2R mediates transendothelial migration of immune cells in 
stressed, injured, or infected arteries. 
The P2Y2R is up-regulated in vascular endothelium in response to arterial injury or 
stress (Seye et al., 2002). Furthermore, in vivo application of the P2Y2R ligand UTP to 
rabbit carotid arteries undergoing perivascular collar-induced stress has been found to 
enhance intimal hyperplasia and monocyte infiltation into the neointima (Seye et al., 
2002) .  These responses suggest that the P2Y2R plays a critical role in initiating an 
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inflammatory response, and studies should be performed to conclusively determine 
whether this subtype of nucleotide receptors contributes significantly to vascular 
inflammation in humans. 
To also address the importance of the P2Y2R in vascular inflammation in vivo, 
P2Y2R knockout (P2Y2R-/-) mice could be used to determine whether nucleotides still 
promote immune cell migration into stressed or injured arteries.  Arterial injury in 
normal versus P2Y2R-/- mice can be induced by placement of a perivascular silicone 
collar around the carotid artery and immunohistochemical analysis would be used to 
assess accumulation of immune cells in the injured artery, including 
monocytes/macrophages, granulocytes, T cells, and dendrocytes.  The effect of the 
P2Y2R agonists (ATP and UTP) on transendothelial migration of immune cells could be 
evaluated by administering these ligands extravascularly through a pump attached to the 
collar.  In addition, vascular inflammatory phenotypes thought to be associated with 
P2Y2R activation (i.e., monocyte chemotaxis, adhesion, transendothelial migration, and 
expression of chemotactic/adhesive proteins including E-selectin, MCP-1, VCAM-1, 
VE-cadherin, osteopontin, and vitronectin) could be analyzed in primary monocytes and 
endothelial cells isolated from normal versus P2Y2R-/- mice or in cultured cells in which 
endogenous P2Y2R expression has been down-regulated with RNAi. In addition, 
monocytes and vascular endothelial cells isolated from normal and P2Y2R-/- mice could 
be used to assess the role of the P2Y2R in ATP/UTP-stimulated chemotaxis, monocyte 
adhesion to endothelial cells, and transendothelial migration of monocytes. 
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